US20060200100A1 - Method and apparatus for supplying gas to an area - Google Patents

Method and apparatus for supplying gas to an area Download PDF

Info

Publication number
US20060200100A1
US20060200100A1 US11/356,929 US35692906A US2006200100A1 US 20060200100 A1 US20060200100 A1 US 20060200100A1 US 35692906 A US35692906 A US 35692906A US 2006200100 A1 US2006200100 A1 US 2006200100A1
Authority
US
United States
Prior art keywords
gas
reservoir
package
oxygen
gases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/356,929
Inventor
Coni Rosati
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/781,965 external-priority patent/US7014630B2/en
Application filed by Individual filed Critical Individual
Priority to US11/356,929 priority Critical patent/US20060200100A1/en
Priority to US11/485,513 priority patent/US8166731B2/en
Publication of US20060200100A1 publication Critical patent/US20060200100A1/en
Priority to US11/899,394 priority patent/US7762045B2/en
Priority to US13/459,680 priority patent/US8900209B2/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/00051Accessories for dressings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/02Adhesive plasters or dressings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/02Adhesive plasters or dressings
    • A61F13/0203Adhesive plasters or dressings having a fluid handling member
    • A61F13/0206Adhesive plasters or dressings having a fluid handling member the fluid handling member being absorbent fibrous layer, e.g. woven or nonwoven absorbent pad, island dressings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/02Adhesive plasters or dressings
    • A61F13/0203Adhesive plasters or dressings having a fluid handling member
    • A61F13/0213Adhesive plasters or dressings having a fluid handling member the fluid handling member being a layer of hydrocoloid, gel forming material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/02Adhesive plasters or dressings
    • A61F13/0203Adhesive plasters or dressings having a fluid handling member
    • A61F13/0226Adhesive plasters or dressings having a fluid handling member characterised by the support layer
    • A61F13/05
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008Introducing ophthalmic products into the ocular cavity or retaining products therein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M35/00Devices for applying media, e.g. remedies, on the human body
    • A61M35/003Portable hand-held applicators having means for dispensing or spreading integral media
    • A61M35/006Portable hand-held applicators having means for dispensing or spreading integral media using sponges, foams, absorbent pads or swabs as spreading means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M35/00Devices for applying media, e.g. remedies, on the human body
    • A61M35/30Gas therapy for therapeutic treatment of the skin
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65BMACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B31/00Packaging articles or materials under special atmospheric or gaseous conditions; Adding propellants to aerosol containers
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D81/00Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
    • B65D81/18Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents providing specific environment for contents, e.g. temperature above or below ambient
    • B65D81/20Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents providing specific environment for contents, e.g. temperature above or below ambient under vacuum or superatmospheric pressure, or in a special atmosphere, e.g. of inert gas
    • B65D81/2069Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents providing specific environment for contents, e.g. temperature above or below ambient under vacuum or superatmospheric pressure, or in a special atmosphere, e.g. of inert gas in a special atmosphere
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F2013/00089Wound bandages
    • A61F2013/0017Wound bandages possibility of applying fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F2013/00089Wound bandages
    • A61F2013/0017Wound bandages possibility of applying fluid
    • A61F2013/00174Wound bandages possibility of applying fluid possibility of applying pressure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H33/00Bathing devices for special therapeutic or hygienic purposes
    • A61H33/14Devices for gas baths with ozone, hydrogen, or the like
    • A61H2033/143Devices for gas baths with ozone, hydrogen, or the like with oxygen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H33/00Bathing devices for special therapeutic or hygienic purposes
    • A61H33/14Devices for gas baths with ozone, hydrogen, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H35/00Baths for specific parts of the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/02Gases
    • A61M2202/0208Oxygen
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65BMACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B25/00Packaging other articles presenting special problems
    • B65B25/008Packaging other articles presenting special problems packaging of contact lenses

Definitions

  • the present invention relates generally to devices (which may also be referred to as apparatuses, systems or products) for supplying/delivering one or more particular gases to a desired area, use of such gas supplying devices, and systems and methods for packaging such devices with one or more particular gases.
  • Oxygen's role in wound healing has been intensively studied.
  • the background section of published parent no. 2004/0260253 A1 presents a discussion of wound recovery with respect to oxygen supply and further teaches how a simple dressing can supply oxygen to a wound area at high concentrations without the need for producing oxygen chemically, electrochemically or from a tethered source.
  • devices disclosed in the '253 publication allow for the delivery of other gases at predetermined gas ratios to tissues and other target areas.
  • This simple means to manipulate and optimize local environments can be used alone or in combination with other materials and/or devices to create additive and sometimes synergistic outcomes (e.g., heat, electrical stimulation, growth factors, and nutrients), or using oxygen in combination with antibiotics topically to enhance antimicrobial effectiveness.
  • synergistic outcomes e.g., heat, electrical stimulation, growth factors, and nutrients
  • embodiments of the present invention include further means to supply oxygen, as well as other gases and gas-ratios, to a wound on a continuous and ambulatory basis, as well as other gases and gas ratios.
  • Local environments may be manipulated in order to accelerate growth of cells, preserve or extend the life of cells and/or tissues, to retard/maintain/accelerate biochemical reactions, to sustain/accelerate/suppress chemical reactions, and the prevention of corrosion.
  • oxygen may be released to manage metabolic processes, in other cases carbon dioxide could be released (or a ratio of oxygen to carbon dioxide, etc.).
  • gas emitting devices may be used as biocides to inhibit the growth of or kill organisms—like the use of oxygen to kill anaerobic organisms or chlorine dioxide to kill bacteria, fungi and algae.
  • Some of the embodiments of the present invention may include further means to supply gases and gas ratios to a local area such as cells, tissues, containers, surfaces and non-biological systems.
  • some embodiments of the invention include methods and devices which saturate and/or super-saturate, absorb or adsorb, or take up gases (hereinafter referred to as “gas infusion”, “gas infusing” or “gas infused”) into a device with a single gas (e.g., oxygen, carbon dioxide), or, in some embodiments, infused with a plurality of gases.
  • gases infusion gas infusing
  • gas infused gases into a device with a single gas (e.g., oxygen, carbon dioxide), or, in some embodiments, infused with a plurality of gases.
  • a device may become infused with a subset of the gas(es) inside a sealed package by diffusing passively from predetermined gas(es) stored in the package to the device also stored in the package.
  • This method can also be used to preserve the gas levels precharged in or on a device by packaging the device with gases that will maintain the predetermined gas levels in the device.
  • the device may be used to deliver the infused gas(es) to a target area.
  • the product may be a medical related product such as a topical dressing or implant infused with oxygen (for example) which can then deliver oxygen to a target area of the body.
  • An eye patch or dressing could be applied to oxygenate the eye for purposes such as to enhance healing or provide oxygen as a nutrient.
  • gas infused and gas emitting health care products may include (but not limited to): injectables, topical agents, contact lenses, implantable lenses, ingested devices, inhaled materials, face masks, socks, boots, insoles, gloves, sutures, pills, dermal fillers, wound healing gels, gum and the like. These products may also contain other therapeutic materials in addition to the infused gas, or may contain agents/ingredients to facilitate the uptake and release of the gas(es). Such embodiments may include a pre-packaged gas-infused gel and/or foam, for supplying one or more predetermined gases to a target environment.
  • some of the embodiments of the present invention may include devices that are capable of providing one or more predetermined gases to a target area (“a gas delivery device”).
  • a gas delivery device may include one or more gas reservoirs which may be formed between similar or dissimilar layers of material or are enveloped within a continuous layer of material.
  • a multi-layer wound device comes pre-filled with a predetermined amount of oxygen between the layers.
  • the top layer is a barrier film that holds the oxygen over the wound, while the bottom layer is a gas permeable membrane, which may be designed to have a specific rate of gas transfer.
  • the bottom layer is typically placed over the wound in some applications, like conventional wound dressings, and can be manufactured with a similar size, weight and feel of conventional dressings or transdermal patches.
  • the top or barrier layer retains the oxygen in the vicinity of the wound, while the bottom or permeable (or porous) layer allows the oxygen to diffuse into the wound at a rate proportional to the gradient (for example), until the wound is saturated.
  • the dressing acts like a local abundant oxygen supply to be used as needed.
  • the geometry can be adjusted from simple rectangular or circular packets to more complicated geometries such as socks, gloves, masks and eye patches for wounds located on the body where there are more contours, bends, crevasses and protuberances.
  • Such a dressing may be provided to a user in a sealed package, and may be pre-filled with a predetermined amount of one or more gases.
  • the package is filled with a predetermined amount of one or more gases (e.g., substantially pure oxygen—preferably 100% oxygen) which may be accomplished using, for example, controlled atmospheric packaging (CAP).
  • gases e.g., substantially pure oxygen—preferably 100% oxygen
  • CAP controlled atmospheric packaging
  • Another embodiment of the invention may include a gas delivery device for supplying one or more predetermined gases to a target environment, where the device may include a reservoir, a gas diffusion portion for communicating gas from the reservoir and include one or more predetermined gases.
  • the device does not generate gas and may be packaged prior to use with the one or more predetermined gases.
  • gases may diffuse through the permeable portion of the device until reaching equilibrium, when the gases and gas concentrations are the same within the package and the reservoir.
  • a gas delivery device for supplying one or more predetermined gases to a target environment is provided, similar to the above-noted embodiment, and also including a preset volume of one or more predetermined gases.
  • a gas delivery device which may be in the form of a contact lens for supplying one or more predetermined gases like oxygen (for example) to a target environment such as the cornea, retina or eye.
  • oxygen for example
  • Oxygen is stored either between layers as gas, or as an oxygen saturated or oxygen carrying solution between the layers and/or absorbed reversibly in a lens material that lacks a reservoir between layers.
  • inventions include devices having one or more reservoirs (or designated areas of the device) pre-filled with one or more predetermined gases (e.g., oxygen) according to a predetermined amount corresponding to levels other than that contained in the ambient atmosphere.
  • the reservoir may be formed between layers of material for such devices, or enveloped within a continuous layer of material, or the material itself may act as a reservoir as it contains gas either in its micro or macro cavities (such as foam or gel) or by reversibly adsorbing or absorbing gas molecules.
  • the gas infused products fill multiple micro-reservoirs with designated gas(es) by coming to equilibrium with the gas for infusion during packaging or in the package.
  • the gas permeates through the product (e.g., a solid, semi-solid, fluid or semi-fluid), diffusing therein (i.e., absorbed/adsorbed) by coming to equilibrium with the gas for infusion in the package.
  • gas infusion of products may be accomplished in the package at a temperature and/or pressure greater than atmosphere in order to hasten or increase the rate or levels of taken up by the product.
  • a method of packaging a gas delivery device that creates a flatter package as one particular advantage.
  • the gas delivery device may comprise a reservoir including one or more predetermined gases, and a gas diffusion portion for communicating the one or more predetermined gases from the reservoir.
  • the gas delivery device may be packaged with the one or more predetermined gases that may or may not be the same gas types or levels as contained in the reservoir.
  • Such a packaging method may include placing the gas delivery device into a package, where the package capable of being substantially gas-impermeable when sealed, and the package may be filled with the one or more predetermined gases and sealed.
  • the port may allow gas to be removed without the need for pressure being applied externally to the package.
  • the self-sealing material seals the puncture.
  • the excess one or more predetermined gases may be released through a valve, which may be a one-way valve. Such valves may release the excess one or more predetermined gases upon the pressure in the package reaching a predetermined level.
  • the method may further include re-sealing the package (e.g., heat sealing).
  • a contact lens case which may include a container holding at least one contact lens and also for optionally holding contact lens solution and one or more predetermined gases at concentrations greater than atmospheric included within the reservoir.
  • a related embodiment may include a contact lens oxygenation system which may include a container for holding a contact lens, an inlet for supplying a flow of oxygen to the container, a supply of oxygen capable of providing a flow of oxygen to the inlet and a one-way valved outlet for releasing excess pressure from the container.
  • a further related embodiment may include a method for oxygenating a contact lens which may include providing at least one contact lens container for holding at least one contact lens in a sealed state, positioning at least one contact lens inside the at least one contact lens container, providing oxygen to the inside of the at least one contact lens container in concentrations greater than atmospheric or ambient pressure.
  • Providing oxygen may include establishing a flow of oxygen into the container.
  • the container may include a one-way valve such that upon the flow of oxygen being established excess pressure is released from within the container upon the pressure reaching a predetermined level.
  • FIG. 1 illustrates one embodiment of a dressing system.
  • FIG. 2 illustrates one embodiment of a packaging system.
  • FIG. 3 illustrates one embodiment of a gas emitting pouch system.
  • FIG. 4 illustrates a flow diagram for utilizing a packaging system according to one embodiment of the invention.
  • FIG. 5 illustrates a flow diagram for utilizing a dressing system according to one embodiment of the invention.
  • FIG. 6 illustrates one embodiment of a pouch system.
  • FIGS. 7A is an illustration of a material for use in a continuous-layer, gas-delivery device comprising a balloon.
  • FIG. 7B is an illustration of a material for use in a continuous-layer, gas-delivery device comprising a tube.
  • FIG. 7C is an illustrations of a material for use in a continuous-layer, gas-delivery device comprising a pouch.
  • FIG. 7D is an illustration of a material for use in a continuous-layer, gas-delivery device comprising an O-ring.
  • FIG. 8 is an illustration of a gas-delivery device according to an embodiment of the invention comprising a contact lens.
  • FIG. 9A is a first cross-sectional view of a packaging system for packaging a gas-delivery device according to an embodiment of the present invention.
  • FIG. 9B is a second cross-sectional view of a packaging system for packaging a gas-delivery device according to an embodiment of the present invention.
  • FIG. 9C is a third cross-sectional view of a packaging system for packaging a gas-delivery device according to an embodiment of the present invention.
  • FIG. 9D is a partial cross-sectional view of a packaging system for packaging a gas-delivery device according to an embodiment of the present invention utilizing a self-sealing material.
  • FIG. 9E is a partial cross-sectional view of a packaging system for packaging a gas-delivery device according to an embodiment of the present invention utilizing a valve type device.
  • FIG. 10 is a perspective view of a contact-lens case capable of being charged with one or more predetermined gases, according to one embodiment of the present invention.
  • FIG. 1 illustrates an example of one embodiment of the invention of an apparatus for supplying one or more gases to a target area.
  • tissue dressing system 100 also known as a gas-delivery device.
  • the dressing system 100 is shown as an exemplary perspective cut-away view for clearer understanding.
  • the dressing system 100 may be configured to contain one or more predetermined gases. While any one or more known gases (or volatiles) may be used, the gases included with the dressing system 100 may particularly include oxygen, carbon dioxide, nitrogen and nitric oxide, and combinations thereof.
  • the dressing system can also be used to supply gases to any target areas that would benefit from a locally controlled gas supply such as containers in which it is desired to retard, accelerate, or maintain biochemical reactions, sustain, accelerate, and/or suppress chemical reactions, corrosion, or inhibit the growth or kill organisms,
  • the dressing system 100 may include a seal 110 , an external barrier (or top layer) 120 , a reservoir 130 , an absorbent ring 140 , an adhesive backing 150 , a permeable film (or bottom layer) 160 , and a compliant porous insert 170 .
  • the reservoir may be formed between the upper and lower layers (e.g., being hermetically sealed around the perimeter), but may also be a separate element to the dressing system, or contained within a continuous layer.
  • the seal 110 is configured to bond the external barrier 120 and the permeable film 160 together such that the reservoir 130 is formed.
  • the external barrier 120 is preferably selected to be non-permeable to gases.
  • the external barrier 120 may be constructed of metallized polyester, ceramic coated polyester, polyvinylidene chloride laminates such as Saranex®, EVOH laminates such as Oxyshield®, or polyamide laminates such as Capran®.
  • the external barrier 120 may be configured to conduct heat or electrical stimulation from an external source to the user.
  • polyethylene or another infrared transmittable material may be utilized as the external barrier 120 .
  • the permeable film 160 is preferably configured to be permeable to gases.
  • the permeable film 160 may be constructed of polyurethane, silicone, polyvinylchloride, polyolefins, and the like, preferably ethylene vinyl alcohol (EVA) or EVA/polyethylene.
  • EVA ethylene vinyl alcohol
  • the reservoir 130 is configured to store a gas while the dressing system 100 is worn by a user.
  • the stored gas within the reservoir 130 is controllably released to the user through the permeable film 160 .
  • the amount of gas released to the user while wearing the dressing system 100 may vary according to the concentration of the gas contained within the reservoir 130 and the material used as the permeable film 160 . Other factors such as temperature and atmospheric pressure may also affect the amount of gas released to the user.
  • the absorbent ring 140 may be located adjacent to the permeable film 160 and may be configured to wick away moisture from the user.
  • the adhesive backing 150 is configured to adhere the dressing system 100 to the user. Further, the adhesive backing 150 may also be utilized to prevent the gas that is delivered through the permeable film 160 to the user from escaping.
  • the adhesive backing 150 may cover the perimeter of the dressing system 100 . In another embodiment, the adhesive backing may cover the entire dressing system 100 and may be integrated with the permeable film 160 . In another embodiment the adhesive may be on the opposite side attaching the top film, for example, to the inside lid surface of a container allowing the gas to transfer through the bottom film over the entire volume of the closed container such as a Petri dish.
  • the adhesive backing may be comprised of adhesive used in commercially available adhesive bandages.
  • the adhesive backing may be comprised of a gel adhesive.
  • the gel adhesive may be comprised of a hydrogel.
  • the gel adhesive may also be reusable, such that the dressing system could be removed from the user and replaced more than once. Examples of gels that may be used are described in U.S. Pat. Nos. 4,839,345, 5,354,790 and 5,583,114.
  • the compliant porous insert 170 is configured to prevent gas debt in areas caused by pressing the external barrier 120 directly on to the permeable film 160 .
  • the compliant porous insert 170 placed within the reservoir 130 and between the external barrier 120 and the permeable film 160 .
  • the proportions of gas-delivery device may be influenced by the diffusion rates of the relevant gases through the permeable portion (e.g., film 160 ), the target gas concentration range (e.g., on the user), and the length of time the gas delivery device is used (e.g., the length of time the dressing system 100 may be worn). If the gas-delivery device includes a seal, then the proportions of the device may be also influenced by the seal integrity between the dressing system 100 and the user.
  • Some embodiments of the present invention for supplying one or more gases to a target area may also include devices having a continuous layer of gas permeable/porous material which, in some aspects, envelops the one or more predetermined gases.
  • a continuous layer geometries may include a balloon, a tube, an O-ring, a pouch, a teabag/sachet, a curved material (e.g., a contact lens) or a combination of the foregoing.
  • Materials used for these various embodiments may depend on the application—biocompatible or bioerodible materials can be used for implantable sustained release devices
  • some embodiments of the present invention include gas infused devices having controlled and/or customized gas diffusion rates. Specifically, such embodiments may include pre-determined diffusion rates which may be determined by controlling the type of membrane being used, the size and/or amount of pores and/or erosion areas.
  • the gas-delivery device in addition to providing gas to a target area, may be configured to deliver biologically beneficial agents such as drugs, minerals, nutrition, amino acids, pH modifiers, anti-microbials (e.g., antibacterials and antifungals), growth factors, and enzymes to the user.
  • biologically beneficial agents such as drugs, minerals, nutrition, amino acids, pH modifiers, anti-microbials (e.g., antibacterials and antifungals), growth factors, and enzymes
  • integrating the delivery systems of the gas with the beneficial agent additives may lead to synergistic effects that are not achieved by just the gas or the beneficial agent additives alone.
  • these biologically beneficial agents may be delivered as microencapsulated agents incorporated in the adhesive backing 150 .
  • the microencapsulated agents may be available in a gel matrix in the dressing cavity 180 , accessible to the wound through pores or perforations, or using conventional transdermal technologies.
  • the dressing system as described herein may further comprise a septum, which is defined herein as any type of septum, valve, Luer-type fitting or any resealable opening through which one or more gases can be introduced into the dressing system, then resealed to prevent the one or more gases from escaping.
  • the dressing system of this embodiment may be applied to the wound, then the one or more gases in the desired ratio may be introduced into the dressing system, e.g., with a syringe.
  • the septum would also allow for refilling of the dressing system, if desired.
  • FIG. 3 illustrates another embodiment according to the present invention—a gas emitting pouch system 300 .
  • the gas emitting pouch system 300 is shown as an exemplary perspective cut-away view to more clearly illustrate the invention.
  • the gas emitting pouch system 300 is configured to contain a gas that is dispensed to the local area surrounding the gas emitting pouch system 300 .
  • the different gases contained within the gas emitting pouch system 300 may include but is not limited to oxygen, carbon dioxide, and/or nitrogen.
  • the gas emitting pouch system 300 may also include a first permeable film 310 , a second permeable film 320 , and a reservoir 330 .
  • the first permeable film 310 is coupled with the second permeable film 320 and forms the reservoir 330 for storing gas within the gas emitting pouch system 300 .
  • the first and second permeable films 310 and 330 may be constructed of the same or different materials such as polyurethane, polyethylene, silicone films, polyvinylchloride, and the like.
  • the reservoir 330 is configured to store a gas while the gas emitting pouch system 300 is being used.
  • the stored gas within the reservoir 330 is controllably released to the area surrounding the gas emitting pouch system 300 through the first and second permeable films 310 and 320 .
  • the amount and rate of gas released through the gas emitting pouch system 300 may vary according to the concentration gradients of the gas across the permeable films that comprise the walls of reservoir 330 and the materials used as the first and second permeable films 310 and 320 .
  • 310 and 320 can be the same or different materials.
  • the amount and rate of release of gas can be different on the opposite sides, this can occur when 310 and 320 have different permeabilities. Other factors such as temperature, humidity and atmospheric pressure may also affect the amount of gas released.
  • the elements comprising the gas emitting pouch system 300 are shown for illustrative purposes only. Deletion or substitution of any shown elements does not depart from the spirit and scope of the invention. Similarly, the addition of new elements does not depart from the spirit and scope of the invention.
  • the gas emitting pouch system 300 is configured prefilled with the desired gas concentrations and is stored within the packaging system 200 ( FIG. 2 ) prior to releasing gas into the surrounding environment, also prefilled with the same gas concentrations as in the gas emitting pouch, in order to maintain the levels in the pouch.
  • the gas within the reservoir 330 within the gas emitting pouch system 300 comes to equilibrium within the packaging system 200 so that both the pouch and the package reach the target concentrations.
  • the gas emitting pouch system 300 is configured to be placed in an environment where the gas stored within the reservoir 330 is released steadily into the surrounding environment, as the gradient doesn't change appreciably.
  • the release rate of gas from the reservoir 330 into the surrounding environment slows as the surrounding environment becomes saturated with the gas. Subsequent to the saturation, the gas emitting pouch system 300 acts as a gas reservoir; as gas is dissipated from the surrounding environment, there is a local supply of gas within the reservoir 330 to be provided to the surrounding environment, governed by the transfer rate across the permeable film.
  • the gas emitting pouch 300 has many applications which may include non-medical applications such as applying the gas emitting pouch 300 to effect environments in containers for any purpose such as lab experiments, food preservation, to accelerate degradation, to prevent corrosion, and the like.
  • FIG. 6 illustrates another example of a pouch system.
  • the pouch system 600 is configured to emit gas into a local environment, similar to the gas emitting pouch system 300 .
  • the pouch system 600 includes a first layer 610 and a second layer 630 .
  • the first layer 610 and the second layer 630 may be permeable to gases.
  • the first layer 610 and the second layer 630 are bonded through an intermediate layer 620 .
  • the intermediate layer 620 provides the pouch system 600 a more resilient and durable seal between the first layer 610 and the second layer 630 by diverting the load so that more robust shear force is applied to a higher bond strength seal rather than strictly a design that puts all the internal pressure and load on a peel strength surface.
  • the seal between the first layer 610 and the second layer 630 is reinforced.
  • One method of achieving the specified oxygen concentration in the reservoir 130 and to create the controlled atmospheric packaging is to (1) assemble dressing, sealing the reservoir with normal atmospheric conditions (about 21% oxygen); (2) place the dressing in a package (e.g., a metallized film package); (3) flush the package with substantially pure oxygen; and (4) sealing the package.
  • the gas in the reservoir 130 will come to equilibrium with the gas in the package via the permeable film 160 .
  • the gas in the reservoir will achieve about 95-98% oxygen.
  • the materials and dimensions used are determined by taking into account these objectives.
  • the final concentration in the reservoir depends upon the volume and ratios of gases.
  • FIG. 2 illustrates an exemplary packaging system 200 .
  • the packaging system 200 is shown as an exemplary perspective cut-away view to more clearly illustrate the invention.
  • the packaging system 200 is configured to contain a gas within an enclosed container 210 , which is within the packaging system.
  • the different gases contained within the dressing system 100 may include but is not limited to oxygen, carbon dioxide, nitrogen, and/or nitric oxide.
  • the enclosed container 210 may also be configured to hold the dressing system 100 as shown and described corresponding to FIG. 1 . Once the enclosed container 210 is sealed, the enclosed container is substantially impermeable; the gas within the enclosed container 210 substantially remains within the enclosed container 210 . Further, the enclosed container 210 utilizes controlled atmospheric packaging (CAP) to maintain the environment within the enclosed container 210 . In one embodiment, CAP is a package with high barrier properties that contains the desired ratio of gases to preserve the internal environment. The gas within the enclosed container 210 may permeate the dressing system 100 through the permeable film 160 .
  • CAP controlled atmospheric packaging
  • a hole may be created in the dressing system (preferably on one side of the dressing, and preferably on the permeable side of the dressing), and the dressing placed in the package.
  • the package is then evacuated which also evacuates the reservoir.
  • the package is then filled with the one or more desired gases (e.g., oxygen) and sealed. Thereafter, the reservoir in the dressing fills with the gases contained in the package.
  • the time it takes for the oxygen to enter the reservoir may be between less than a minute to several hours, and more preferably between about several minutes and several hours. It suffices to say, by the time the packaged dressing is sold, the reservoir contains sufficient amount of the packaged gases to supply a wound or other use.
  • the hole in the dressing is sized so that upon opening of the package and removal/use of the dressing, a negligible amount of oxygen is released from the reservoir prior to application to the intended target area.
  • CAP gas amounts in the package are sufficiently high so as to create a bulky package.
  • packaging for a wound dressing may be inflated with at least oxygen gas, causing the package to expand such that the package is bulky and much larger than the wound dressing. After a period of time sufficient enough to allow the oxygen to penetrate the dressing the remaining gas or a portion of the gas may be removed from the package. This allows the final package to be smaller and thus, shipped and distributed more easily.
  • the packaging system 200 may be utilized to store the dressing system 100 without degrading the gas stored within the reservoir 130 within the dressing system 100 when the gas within the reservoir 130 and the gas within the enclosed container 210 are the same.
  • the packaging system 200 may be utilized to change the concentrations of gases in the dressing system 100 .
  • the gas constituents stored within the enclosed container 210 diffuse into the dressing system 100 when the concentration of the gas within the container 210 is higher in concentration compared to the gas within the dressing system 100 .
  • the gas constituents stored within the dressing system 100 diffuse into the container 210 when the concentration of the gas within the container 210 is lower in concentration compared to the gas within the dressing system 100 .
  • the gases may diffuse through the permeable film 160 until the constituents reach equilibrium, the same concentrations on both sides of the permeable film.
  • gas infusion may be accomplished in a barrier package at a temperature and/or pressure greater than atmosphere in order to hasten or increase the levels of taken up by a device.
  • Another embodiment of the packaging system comprises any of the packaging systems described herein and further comprises a septum, which as defined herein may be a septum, a valve, Luer lock or any resealable opening, through which one or more gases can be introduced into the packaging system, then resealed to prevent gases from escaping.
  • the packaging system may be charged with the one or more gases in the desired ratio on site (e.g., hospital, doctor's office).
  • the flow diagram in FIG. 4 illustrates an exemplary process of utilizing the packaging system 200 according to one embodiment.
  • a gas-retaining object is placed within the packaging system 200 .
  • the gas-retaining object is the dressing system 100 .
  • the gas-retaining object is gas emitting pouch system 300 .
  • the gas-retaining object may be any item that is configured to retain and controllably release a gas from the object.
  • the packaging system 200 is flushed with a gas.
  • the packaging system 200 is flushed with the same gas contained with the gas-retaining object.
  • the dressing system 100 may be pre-filled with oxygen and placed within the packaging system. By flushing the packaging system 200 with oxygen, the packaging system 200 ensures that the dressing system 100 retains the pre-filled oxygen content.
  • the packaging system 200 is flushed with a different gas than the gas contained with the gas-retaining object.
  • the dressing system 100 may contain air that contains other gases in addition to oxygen and may be placed within the packaging system 200 .
  • the packaging system 200 diffuses the dressing system 100 with additional oxygen until the gas within the packaging system 200 and the gas within the dressing system 100 have reached an equilibrium.
  • the packaging system 200 is sealed after placing the gas-retaining object within the packaging system 200 and flushing the packaging system 200 with a gas.
  • the packaging system 200 may be opened to remove the gas-retaining object.
  • the packaging system 200 may be utilized to store the gas-retaining object without degrading the gas within the gas-retaining object.
  • the packaging system 200 may be utilized to infuse the gas-retaining object with a gas.
  • Mechanisms for carrying out the removal of remaining gases (or a portion thereof) from the packaging may include devices such as a rubber septum or a self-sealing material provided for on a wall of the package.
  • a rubber septum located on the interior (or between layers if multiple layers of material are used)
  • the wall 902 of the package includes a self-sealing material 904 .
  • the self-sealing material allows a puncture through a wall of the package to self-seal, preferably after excess gas has escaped from the puncture.
  • the package is punctured and pressure is applied to the package to force out the remaining materials (e.g., gases and or therapeutic materials) which have not been absorbed by the device.
  • the puncture device e.g., a needle
  • the puncture hole is then sealed from the flow of the self-sealing material.
  • the package may be vented and re-sealed as shown in FIGS. 9A-9C .
  • a puncture device 906 may be used to puncture a wall 908 of the package which contains a gas delivery device 910 .
  • the ends 912 may be heat sealed.
  • FIG. 9B illustrates gas excess gas(es) escaping out of the puncture hole 914 (arrows B), which may be driven by pressure (arrows A) applied to the package. Thereafter, the end of the package may be heat sealed at a location of the puncture 914 which eliminates the puncture/vent from the final package.
  • the package may include a one-way valve 916 on a wall 918 of the package as shown in FIG. 9E .
  • the valve may comprise one or more flaps 920 which allow one-way travel of gas—i.e., out of the package.
  • pressure may be applied to the outside of the package which forces the valve 916 open and the excess agent out of the package.
  • the flow diagram in FIG. 5 illustrates an exemplary process of utilizing the dressing system 100 according to one embodiment. Accordingly, in Block 510 , the dressing system 100 is removed from a packaging.
  • the dressing system 100 is adhered to a user.
  • the dressing system 100 may cover a wound or broken skin of the user.
  • the dressing system 100 utilizes the adhesive backing 150 to adhere the dressing system 100 to the user.
  • a seal is formed between the dressing system 100 and the user.
  • the adhesive backing 150 forms the seal between the dressing system 100 and the user.
  • gas is supplied from the dressing system 100 to the user.
  • the permeable film 160 is positioned over the wound or broken skin of the user and allows the gas from the dressing system 100 to be supplied to wound of the user.
  • the permeable film 160 may be positioned over intact skin of the user and allows the gas from the dressing system 100 to be supplied to the skin of the user.
  • the gas from the dressing system 100 may be supplied to the skin of the user.
  • oxygen there are numerous practical applications in supplying oxygen to intact skin such as treating sun or radiation damaged skin, exfoliated skin, dermabraded skin, or providing nourishment to aged skin. There may be a synergistic effect with topical agents as well.
  • the gas within the reservoir 130 of the dressing system 100 may be stored until additional gas is supplied to the user through the permeable film 160 .
  • a method and system for oxygenating or re-oxygenating contact lenses between uses is provided.
  • these embodiments include taking one or more contact lenses and placing them into a container that may be charged (and/or re-charged) with oxygen (or another specific gas or gases). Accordingly, users may then be able to oxygenate their own contact lenses.
  • the lenses may be inserted into the case, for example, by popping them thru a gentle one way valve, or, alternatively, the lenses may be placed in a contact lens case and the case may then be oxygenated—either by inflating a collapsed case or flushing oxygen thru a rigid case (for example).
  • the rigid case accordingly, may include a venting mechanism for escaped gas.
  • FIG. 10 illustrates an example of a contact lens case 1000 having a re-sealable port 1002 a and 1002 b , to which oxygen source 1004 can be flowed into.
  • One-way valve vents 1006 a and 1006 b allows gases to flow out of each respective chamber of the contact lens case so as to insure fresh oxygen from oxygen source 1004 is contained in each chamber.
  • These embodiments may, in addition to being used for contact lenses, also be used to oxygenate contacts that are used as “bandage lenses” after photorefractive keratectomy laser surgery for nearsightedness (for example). Keratectomy is a procedure where the outer cell layer of the cornea is removed, resulting in a wound that is a large abrasion on the eye, which is extremely painful to the patient. Accordingly, such bandage lenses are used as a protective covering on the cornea once anesthetic wears off.
  • Oxygen can be supplied a variety of ways to the contact lens case/container: e.g., via compressed oxygen stored in a cylinder or spray-can, or in prefilled, non-pressurized oxygen packages that allow the user to insert the device without leaking oxygen, and then open the package.
  • some embodiments of the invention may include contact-lens cases which include a reservoir of oxygen that, release oxygen to the area in which the contact lens is stored.
  • Still other embodiments of the invention include uses and methods for charging gas carrying media, such as oxygenating oxygen carrier gels, foams or solutions. For example, placing these materials into an impermeable package and filling the package with the predetermined gas, these materials become charged or saturated with gas while inside the package. Whether gases are supplied via a reservoir created between a barrier layer and a gas-permeable layer or through a gas-permeable continuous layer, the one or more gases may be stored in micro- or nano-reservoirs. These multiplicative reversible gas carrying reservoirs may include, for example, micro- or nano-particles, beads, spheres, mems (microelectro-mechanical systems), pigments or liposomes, for delivery to the target area. Further descriptions of such materials (e.g., repirocytes) can be found at:
  • respirocyte includes “molecular sorting rotors” which have been described by Drexler K E. Nanosystems: Molecular Machinery, Manufacturing, and Computation . New York: John Wiley & Sons, 1992. These tiny rotors have binding site “pockets” along their rims that are exposed alternately to the gas source to deliver or infuse gas from or into an interior microchamber. Once the binding site rotates to expose it to the interior chamber, the bound molecules are forcibly ejected by rods thrust outward by the cam surface. This can work equivalently in the reverse direction by ejecting gas after interior chamber has been charged with gas. These theoretical respirocytes can be designed to precisely take on and dispense oxygen and carbon dioxide separately or simultaneously under various conditions).
  • reversible oxygen carriers include transport pigments which are conjugated proteins, or proteins complexed with another organic molecule or with one or more metal atoms. Transport pigments contain metal atoms such as Cu 2+ or Fe 3+ .
  • transport pigments contain metal atoms such as Cu 2+ or Fe 3+ .
  • other natural oxygen carriers include hemocyanin, a blue copper-based pigment found in molluscs and crustaceans and chlorocruorin, a green iron-based pigment found in marine polychaete worms, and different oxides of vanadium.
  • reversible oxygen-carriers include cobalt-based porphyrins such as coboglobin (a cobalt-based analog to hemoglobin) and cobaltodihistidine, and other metallic porphyrins, iron-indigo compounds, iridium complexes such as chloro-carbonyl-bis(triphenylphosphine)-iridium, a cobalt/ammonia complex described by (Hearon J Z, Burke D, Schade A L. Physicochemical studies of reversible and irreversible complexes of cobalt, histidine, and molecular oxygen. J Natl Cancer Inst 1949; 9:337-377), zeolite-bound divalent chromium, nonporphyrin lacunar iron complexes, and heme-linked NADPH oxidase.
  • cobalt-based porphyrins such as coboglobin (a cobalt-based analog to hemoglobin) and cobaltodihistidine
  • Still other embodiments may include a device which includes a semi-solid, fluid or semi-fluid, gas infused material (i.e., gas being absorbed/adsorbed).
  • a semi-solid, fluid or semi-fluid, gas infused material i.e., gas being absorbed/adsorbed.
  • Such semi-solid or semi-fluid products may include a gel, an ointment or a foam which is infused with one or more gases.
  • Such materials may be cast on a film, and positioned over a wound or proximate a target where the desired gas(es) is to be provided.
  • Such materials also may, as indicated above, be contained in a reservoir.
  • Bioresorbable materials refers to a group of materials that have been shown to clinically resorb in living tissue (e.g., the human body), and include such products as sutures, dermal fillers and bone fillers (for example). According, such gas-delivery devices according to some embodiments of the present invention, when implanted into tissue (e.g., bone, cartilage, subdermal fat), biodegrade as they release (or when upon releasing a majority of) its stored gas such as oxygen or nitric oxide.
  • tissue e.g., bone, cartilage, subdermal fat
  • bioresorbable materials can include calcium phosphates, hydroxyapatite, apatites, calcium sulfates, bioresorbable polymers, collagen, gelatin, and bioactive glass.
  • Calcium phosphates include alpha-tri-calcium phosphate and beta-tri-calcium phosphate.
  • Still other embodiments of the invention include uses and methods for storing and/or preserving oxygen media, tissue, and/or cells (e.g., red-blood cells), as well as uses and methods for oxygenating oxygen carrier solutions.
  • oxygen carrier solutions may include perfluorocarbons, polyhemoglobins, molecularly modified hemoglobin, and oxygenated Krebs solution.
  • Still other embodiments of the invention include methods to oxygenate scaffolds, tissues, artificial skin that may contain fibrinogen, collagen, hemoglobin, myoglobin, or other reversible oxygen binding agents for use as wound or aesthetic dressings.
  • fibrinogen fibrinogen, collagen, hemoglobin, myoglobin, or other reversible oxygen binding agents for use as wound or aesthetic dressings.

Abstract

Embodiments of the present invention are directed to various designs and packaging methods for a gas delivery device and materials for supplying one or more predetermined gases to a target area as well as to application specific opthamological embodiments. With regard to the gas delivery device, the device may include a reservoir, a gas diffusion portion for communicating gas from the reservoir and one or more predetermined gases at concentrations greater than atmospheric contained within the reservoir, wherein the device does not generate gas and may be packaged prior to use with the one or more predetermined gases.

Description

    RELATED APPLICATIONS
  • This application is a continuation-in-part (CIP) application to U.S. published application, publication no. 2004/0260253 A1 (U.S. application Ser. No. 10/781,965) filed Feb. 18, 2004, entitled, “Tissue Dressing Having Gas Reservoir”, which claims priority to U.S. Application Ser. No. 60/479,745, filed on Jun. 18, 2003. The present application also claims priority to U.S. provisional patent application Nos. 60/654,037, filed Feb. 17, 2005, entitled, “Packaging Products with a Gas and Products For Releasing the Gas Upon Use”; 60/662,019, filed Mar. 14, 2005, entitled, “Methods and Apparatuses for Packaging Products with a Gas”; and 60/711,796, filed Aug. 26, 2005, entitled, “Methods and Applications related to Oxygen Charged Tissue Dressings”. All of the foregoing disclosures are herein incorporated by reference in their entirety.
  • FIELD OF THE INVENTION
  • The present invention relates generally to devices (which may also be referred to as apparatuses, systems or products) for supplying/delivering one or more particular gases to a desired area, use of such gas supplying devices, and systems and methods for packaging such devices with one or more particular gases.
  • BACKGROUND OF THE INVENTION
  • This application includes citations to various publications, patent applications and issued patents, each of which is herein incorporated by reference in its entirety.
  • Oxygen's role in wound healing has been intensively studied. In that regard, the background section of published parent no. 2004/0260253 A1 (the '253 publication) presents a discussion of wound recovery with respect to oxygen supply and further teaches how a simple dressing can supply oxygen to a wound area at high concentrations without the need for producing oxygen chemically, electrochemically or from a tethered source. In addition, devices disclosed in the '253 publication allow for the delivery of other gases at predetermined gas ratios to tissues and other target areas. This simple means to manipulate and optimize local environments can be used alone or in combination with other materials and/or devices to create additive and sometimes synergistic outcomes (e.g., heat, electrical stimulation, growth factors, and nutrients), or using oxygen in combination with antibiotics topically to enhance antimicrobial effectiveness.
  • SUMMARY OF THE INVENTION
  • In view of oxygen's benefits to speed healing and the reduction of infection and pain for wounds, whether on the surface or interior of tissues, embodiments of the present invention include further means to supply oxygen, as well as other gases and gas-ratios, to a wound on a continuous and ambulatory basis, as well as other gases and gas ratios.
  • Beyond wounds, there are benefits to manipulating local environments with one or more predetermined gases. Local environments may be manipulated in order to accelerate growth of cells, preserve or extend the life of cells and/or tissues, to retard/maintain/accelerate biochemical reactions, to sustain/accelerate/suppress chemical reactions, and the prevention of corrosion. For example, attaching a gas emitting pouch to the inside lid of a petri dish to preserve cells. In some cases, oxygen may be released to manage metabolic processes, in other cases carbon dioxide could be released (or a ratio of oxygen to carbon dioxide, etc.). In still other cases, gas emitting devices may be used as biocides to inhibit the growth of or kill organisms—like the use of oxygen to kill anaerobic organisms or chlorine dioxide to kill bacteria, fungi and algae. Some of the embodiments of the present invention may include further means to supply gases and gas ratios to a local area such as cells, tissues, containers, surfaces and non-biological systems.
  • Accordingly, some embodiments of the invention include methods and devices which saturate and/or super-saturate, absorb or adsorb, or take up gases (hereinafter referred to as “gas infusion”, “gas infusing” or “gas infused”) into a device with a single gas (e.g., oxygen, carbon dioxide), or, in some embodiments, infused with a plurality of gases. Such a device may become infused with a subset of the gas(es) inside a sealed package by diffusing passively from predetermined gas(es) stored in the package to the device also stored in the package. This method can also be used to preserve the gas levels precharged in or on a device by packaging the device with gases that will maintain the predetermined gas levels in the device. Upon opening the sealed package, the device may be used to deliver the infused gas(es) to a target area. For example, the product may be a medical related product such as a topical dressing or implant infused with oxygen (for example) which can then deliver oxygen to a target area of the body. An eye patch or dressing, for example, could be applied to oxygenate the eye for purposes such as to enhance healing or provide oxygen as a nutrient.
  • Other examples of gas infused and gas emitting health care products may include (but not limited to): injectables, topical agents, contact lenses, implantable lenses, ingested devices, inhaled materials, face masks, socks, boots, insoles, gloves, sutures, pills, dermal fillers, wound healing gels, gum and the like. These products may also contain other therapeutic materials in addition to the infused gas, or may contain agents/ingredients to facilitate the uptake and release of the gas(es). Such embodiments may include a pre-packaged gas-infused gel and/or foam, for supplying one or more predetermined gases to a target environment.
  • Accordingly, some of the embodiments of the present invention may include devices that are capable of providing one or more predetermined gases to a target area (“a gas delivery device”). Such embodiments may include one or more gas reservoirs which may be formed between similar or dissimilar layers of material or are enveloped within a continuous layer of material.
  • In one embodiment, a multi-layer wound device (“dressing”) comes pre-filled with a predetermined amount of oxygen between the layers. The top layer is a barrier film that holds the oxygen over the wound, while the bottom layer is a gas permeable membrane, which may be designed to have a specific rate of gas transfer. The bottom layer is typically placed over the wound in some applications, like conventional wound dressings, and can be manufactured with a similar size, weight and feel of conventional dressings or transdermal patches. The top or barrier layer retains the oxygen in the vicinity of the wound, while the bottom or permeable (or porous) layer allows the oxygen to diffuse into the wound at a rate proportional to the gradient (for example), until the wound is saturated. The dressing acts like a local abundant oxygen supply to be used as needed. The geometry can be adjusted from simple rectangular or circular packets to more complicated geometries such as socks, gloves, masks and eye patches for wounds located on the body where there are more contours, bends, crevasses and protuberances.
  • Such a dressing according to some of the embodiments may be provided to a user in a sealed package, and may be pre-filled with a predetermined amount of one or more gases. In one embodiment, the package is filled with a predetermined amount of one or more gases (e.g., substantially pure oxygen—preferably 100% oxygen) which may be accomplished using, for example, controlled atmospheric packaging (CAP).When the gases in the reservoir are different in type or concentration than gases sealed in the package, gases diffuse through the permeable portion of the dressing until reaching equilibrium when the gases and gas concentrations are the same within the package and the reservoir. This passive diffusion until equilibrium is a simple method to infuse or charge the reservoir with the desired gas levels.
  • Another embodiment of the invention may include a gas delivery device for supplying one or more predetermined gases to a target environment, where the device may include a reservoir, a gas diffusion portion for communicating gas from the reservoir and include one or more predetermined gases. The device does not generate gas and may be packaged prior to use with the one or more predetermined gases. As in the previous embodiment, when the gases in the reservoir are different in type or concentration than the gases sealed in the package, gases may diffuse through the permeable portion of the device until reaching equilibrium, when the gases and gas concentrations are the same within the package and the reservoir.
  • In another embodiment of the invention, a gas delivery device for supplying one or more predetermined gases to a target environment is provided, similar to the above-noted embodiment, and also including a preset volume of one or more predetermined gases.
  • Another embodiment of the invention includes a gas delivery device which may be in the form of a contact lens for supplying one or more predetermined gases like oxygen (for example) to a target environment such as the cornea, retina or eye. Oxygen is stored either between layers as gas, or as an oxygen saturated or oxygen carrying solution between the layers and/or absorbed reversibly in a lens material that lacks a reservoir between layers.
  • Other embodiments of the invention include devices having one or more reservoirs (or designated areas of the device) pre-filled with one or more predetermined gases (e.g., oxygen) according to a predetermined amount corresponding to levels other than that contained in the ambient atmosphere. The reservoir may be formed between layers of material for such devices, or enveloped within a continuous layer of material, or the material itself may act as a reservoir as it contains gas either in its micro or macro cavities (such as foam or gel) or by reversibly adsorbing or absorbing gas molecules.
  • The gas infused products according to some embodiments fill multiple micro-reservoirs with designated gas(es) by coming to equilibrium with the gas for infusion during packaging or in the package. In some embodiments, the gas permeates through the product (e.g., a solid, semi-solid, fluid or semi-fluid), diffusing therein (i.e., absorbed/adsorbed) by coming to equilibrium with the gas for infusion in the package. In other embodiments, gas infusion of products may be accomplished in the package at a temperature and/or pressure greater than atmosphere in order to hasten or increase the rate or levels of taken up by the product.
  • In another embodiment of the invention, a method of packaging a gas delivery device is described that creates a flatter package as one particular advantage. The gas delivery device may comprise a reservoir including one or more predetermined gases, and a gas diffusion portion for communicating the one or more predetermined gases from the reservoir. The gas delivery device may be packaged with the one or more predetermined gases that may or may not be the same gas types or levels as contained in the reservoir. Such a packaging method may include placing the gas delivery device into a package, where the package capable of being substantially gas-impermeable when sealed, and the package may be filled with the one or more predetermined gases and sealed. Then, after a predetermined period of time has elapsed, pressure is applied to the outside of the package to release excess gas through a port or a puncture, and then resealed either by a self sealing design (self-sealing material included around the port or puncture) or via an external operation (such as heat sealing). In another embodiment, the port may allow gas to be removed without the need for pressure being applied externally to the package.
  • In the above-noted embodiment, after the pressure to the outside of the package is removed, the self-sealing material seals the puncture. Alternatively or in addition thereto, the excess one or more predetermined gases may be released through a valve, which may be a one-way valve. Such valves may release the excess one or more predetermined gases upon the pressure in the package reaching a predetermined level.
  • Further to the above-noted embodiment, immediately prior to removing the pressure applied to the outside of the package to release the excess one or more predetermined gases, the method may further include re-sealing the package (e.g., heat sealing).
  • Other embodiments of the invention may be directed to a contact lens case which may include a container holding at least one contact lens and also for optionally holding contact lens solution and one or more predetermined gases at concentrations greater than atmospheric included within the reservoir.
  • A related embodiment may include a contact lens oxygenation system which may include a container for holding a contact lens, an inlet for supplying a flow of oxygen to the container, a supply of oxygen capable of providing a flow of oxygen to the inlet and a one-way valved outlet for releasing excess pressure from the container.
  • A further related embodiment may include a method for oxygenating a contact lens which may include providing at least one contact lens container for holding at least one contact lens in a sealed state, positioning at least one contact lens inside the at least one contact lens container, providing oxygen to the inside of the at least one contact lens container in concentrations greater than atmospheric or ambient pressure. Providing oxygen may include establishing a flow of oxygen into the container. Moreover, the container may include a one-way valve such that upon the flow of oxygen being established excess pressure is released from within the container upon the pressure reaching a predetermined level.
  • These and other embodiments, objects and advantages of the system will become more apparent with reference to the following detailed description and attached figures.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate one embodiment of the invention and, together with the description, explain one embodiment of the invention. In the drawings,
  • FIG. 1 illustrates one embodiment of a dressing system.
  • FIG. 2 illustrates one embodiment of a packaging system.
  • FIG. 3 illustrates one embodiment of a gas emitting pouch system.
  • FIG. 4 illustrates a flow diagram for utilizing a packaging system according to one embodiment of the invention.
  • FIG. 5 illustrates a flow diagram for utilizing a dressing system according to one embodiment of the invention.
  • FIG. 6 illustrates one embodiment of a pouch system.
  • FIGS. 7A is an illustration of a material for use in a continuous-layer, gas-delivery device comprising a balloon.
  • FIG. 7B is an illustration of a material for use in a continuous-layer, gas-delivery device comprising a tube.
  • FIG. 7C is an illustrations of a material for use in a continuous-layer, gas-delivery device comprising a pouch.
  • FIG. 7D is an illustration of a material for use in a continuous-layer, gas-delivery device comprising an O-ring.
  • FIG. 8 is an illustration of a gas-delivery device according to an embodiment of the invention comprising a contact lens.
  • FIG. 9A is a first cross-sectional view of a packaging system for packaging a gas-delivery device according to an embodiment of the present invention.
  • FIG. 9B is a second cross-sectional view of a packaging system for packaging a gas-delivery device according to an embodiment of the present invention.
  • FIG. 9C is a third cross-sectional view of a packaging system for packaging a gas-delivery device according to an embodiment of the present invention.
  • FIG. 9D is a partial cross-sectional view of a packaging system for packaging a gas-delivery device according to an embodiment of the present invention utilizing a self-sealing material.
  • FIG. 9E is a partial cross-sectional view of a packaging system for packaging a gas-delivery device according to an embodiment of the present invention utilizing a valve type device.
  • FIG. 10 is a perspective view of a contact-lens case capable of being charged with one or more predetermined gases, according to one embodiment of the present invention.
  • DETAILED DESCRIPTION
  • FIG. 1 illustrates an example of one embodiment of the invention of an apparatus for supplying one or more gases to a target area. With reference to use of such an embodiment on biological tissue, this embodiment may be referred to herein as a tissue dressing system 100 (also known as a gas-delivery device). The dressing system 100 is shown as an exemplary perspective cut-away view for clearer understanding. The dressing system 100 may be configured to contain one or more predetermined gases. While any one or more known gases (or volatiles) may be used, the gases included with the dressing system 100 may particularly include oxygen, carbon dioxide, nitrogen and nitric oxide, and combinations thereof. The dressing system can also be used to supply gases to any target areas that would benefit from a locally controlled gas supply such as containers in which it is desired to retard, accelerate, or maintain biochemical reactions, sustain, accelerate, and/or suppress chemical reactions, corrosion, or inhibit the growth or kill organisms,
  • The dressing system 100 may include a seal 110, an external barrier (or top layer) 120, a reservoir 130, an absorbent ring 140, an adhesive backing 150, a permeable film (or bottom layer) 160, and a compliant porous insert 170. As shown, the reservoir may be formed between the upper and lower layers (e.g., being hermetically sealed around the perimeter), but may also be a separate element to the dressing system, or contained within a continuous layer. To that end, in one embodiment, the seal 110 is configured to bond the external barrier 120 and the permeable film 160 together such that the reservoir 130 is formed.
  • The external barrier 120 is preferably selected to be non-permeable to gases. For example, the external barrier 120 may be constructed of metallized polyester, ceramic coated polyester, polyvinylidene chloride laminates such as Saranex®, EVOH laminates such as Oxyshield®, or polyamide laminates such as Capran®. In one embodiment, the external barrier 120 may be configured to conduct heat or electrical stimulation from an external source to the user. For example, polyethylene or another infrared transmittable material may be utilized as the external barrier 120.
  • The permeable film 160 is preferably configured to be permeable to gases. For example, the permeable film 160 may be constructed of polyurethane, silicone, polyvinylchloride, polyolefins, and the like, preferably ethylene vinyl alcohol (EVA) or EVA/polyethylene.
  • The reservoir 130 is configured to store a gas while the dressing system 100 is worn by a user. In one embodiment, the stored gas within the reservoir 130 is controllably released to the user through the permeable film 160. The amount of gas released to the user while wearing the dressing system 100 may vary according to the concentration of the gas contained within the reservoir 130 and the material used as the permeable film 160. Other factors such as temperature and atmospheric pressure may also affect the amount of gas released to the user.
  • The absorbent ring 140 may be located adjacent to the permeable film 160 and may be configured to wick away moisture from the user. In addition, the adhesive backing 150 is configured to adhere the dressing system 100 to the user. Further, the adhesive backing 150 may also be utilized to prevent the gas that is delivered through the permeable film 160 to the user from escaping. In one embodiment, the adhesive backing 150 may cover the perimeter of the dressing system 100. In another embodiment, the adhesive backing may cover the entire dressing system 100 and may be integrated with the permeable film 160. In another embodiment the adhesive may be on the opposite side attaching the top film, for example, to the inside lid surface of a container allowing the gas to transfer through the bottom film over the entire volume of the closed container such as a Petri dish.
  • Examples of the types of adhesive that may be used in the present invention are described in U.S. Pat. Nos. 6,284,941 and 5,308,887. In one embodiment, the adhesive backing may be comprised of adhesive used in commercially available adhesive bandages. In another embodiment, the adhesive backing may be comprised of a gel adhesive. The gel adhesive may be comprised of a hydrogel. The gel adhesive may also be reusable, such that the dressing system could be removed from the user and replaced more than once. Examples of gels that may be used are described in U.S. Pat. Nos. 4,839,345, 5,354,790 and 5,583,114.
  • The compliant porous insert 170 is configured to prevent gas debt in areas caused by pressing the external barrier 120 directly on to the permeable film 160. In one embodiment, the compliant porous insert 170 placed within the reservoir 130 and between the external barrier 120 and the permeable film 160.
  • The proportions of gas-delivery device according to embodiments of the present invention (e.g., dressing system 100 ) may be influenced by the diffusion rates of the relevant gases through the permeable portion (e.g., film 160 ), the target gas concentration range (e.g., on the user), and the length of time the gas delivery device is used (e.g., the length of time the dressing system 100 may be worn). If the gas-delivery device includes a seal, then the proportions of the device may be also influenced by the seal integrity between the dressing system 100 and the user.
  • Some embodiments of the present invention for supplying one or more gases to a target area may also include devices having a continuous layer of gas permeable/porous material which, in some aspects, envelops the one or more predetermined gases. As shown in FIGS. 7A-7E, such continuous layer geometries may include a balloon, a tube, an O-ring, a pouch, a teabag/sachet, a curved material (e.g., a contact lens) or a combination of the foregoing. Materials used for these various embodiments may depend on the application—biocompatible or bioerodible materials can be used for implantable sustained release devices
  • It is worth noting that some embodiments of the present invention include gas infused devices having controlled and/or customized gas diffusion rates. Specifically, such embodiments may include pre-determined diffusion rates which may be determined by controlling the type of membrane being used, the size and/or amount of pores and/or erosion areas.
  • In some embodiments, in addition to providing gas to a target area, the gas-delivery device may be configured to deliver biologically beneficial agents such as drugs, minerals, nutrition, amino acids, pH modifiers, anti-microbials (e.g., antibacterials and antifungals), growth factors, and enzymes to the user. In one embodiment, integrating the delivery systems of the gas with the beneficial agent additives may lead to synergistic effects that are not achieved by just the gas or the beneficial agent additives alone. In one embodiment, these biologically beneficial agents may be delivered as microencapsulated agents incorporated in the adhesive backing 150. In another embodiment, the microencapsulated agents may be available in a gel matrix in the dressing cavity 180, accessible to the wound through pores or perforations, or using conventional transdermal technologies.
  • In another embodiment, the dressing system as described herein may further comprise a septum, which is defined herein as any type of septum, valve, Luer-type fitting or any resealable opening through which one or more gases can be introduced into the dressing system, then resealed to prevent the one or more gases from escaping. The dressing system of this embodiment may be applied to the wound, then the one or more gases in the desired ratio may be introduced into the dressing system, e.g., with a syringe. The septum would also allow for refilling of the dressing system, if desired.
  • FIG. 3 illustrates another embodiment according to the present invention—a gas emitting pouch system 300. The gas emitting pouch system 300 is shown as an exemplary perspective cut-away view to more clearly illustrate the invention. In one embodiment, the gas emitting pouch system 300 is configured to contain a gas that is dispensed to the local area surrounding the gas emitting pouch system 300. For example, the different gases contained within the gas emitting pouch system 300 may include but is not limited to oxygen, carbon dioxide, and/or nitrogen.
  • The gas emitting pouch system 300 may also include a first permeable film 310, a second permeable film 320, and a reservoir 330.
  • In one embodiment, the first permeable film 310 is coupled with the second permeable film 320 and forms the reservoir 330 for storing gas within the gas emitting pouch system 300. For example, the first and second permeable films 310 and 330 may be constructed of the same or different materials such as polyurethane, polyethylene, silicone films, polyvinylchloride, and the like.
  • The reservoir 330 is configured to store a gas while the gas emitting pouch system 300 is being used. In one embodiment, the stored gas within the reservoir 330 is controllably released to the area surrounding the gas emitting pouch system 300 through the first and second permeable films 310 and 320.
  • The amount and rate of gas released through the gas emitting pouch system 300 may vary according to the concentration gradients of the gas across the permeable films that comprise the walls of reservoir 330 and the materials used as the first and second permeable films 310 and 320. 310 and 320 can be the same or different materials. The amount and rate of release of gas can be different on the opposite sides, this can occur when 310 and 320 have different permeabilities. Other factors such as temperature, humidity and atmospheric pressure may also affect the amount of gas released.
  • The elements comprising the gas emitting pouch system 300 are shown for illustrative purposes only. Deletion or substitution of any shown elements does not depart from the spirit and scope of the invention. Similarly, the addition of new elements does not depart from the spirit and scope of the invention.
  • In one embodiment, the gas emitting pouch system 300 is configured prefilled with the desired gas concentrations and is stored within the packaging system 200 (FIG. 2) prior to releasing gas into the surrounding environment, also prefilled with the same gas concentrations as in the gas emitting pouch, in order to maintain the levels in the pouch. In another embodiment, the gas within the reservoir 330 within the gas emitting pouch system 300 comes to equilibrium within the packaging system 200 so that both the pouch and the package reach the target concentrations.
  • In one embodiment, the gas emitting pouch system 300 is configured to be placed in an environment where the gas stored within the reservoir 330 is released steadily into the surrounding environment, as the gradient doesn't change appreciably. In another embodiment, the release rate of gas from the reservoir 330 into the surrounding environment slows as the surrounding environment becomes saturated with the gas. Subsequent to the saturation, the gas emitting pouch system 300 acts as a gas reservoir; as gas is dissipated from the surrounding environment, there is a local supply of gas within the reservoir 330 to be provided to the surrounding environment, governed by the transfer rate across the permeable film.
  • The gas emitting pouch 300 has many applications which may include non-medical applications such as applying the gas emitting pouch 300 to effect environments in containers for any purpose such as lab experiments, food preservation, to accelerate degradation, to prevent corrosion, and the like.
  • FIG. 6 illustrates another example of a pouch system. The pouch system 600 is configured to emit gas into a local environment, similar to the gas emitting pouch system 300. The pouch system 600 includes a first layer 610 and a second layer 630. The first layer 610 and the second layer 630 may be permeable to gases. In one embodiment, the first layer 610 and the second layer 630 are bonded through an intermediate layer 620. The intermediate layer 620 provides the pouch system 600 a more resilient and durable seal between the first layer 610 and the second layer 630 by diverting the load so that more robust shear force is applied to a higher bond strength seal rather than strictly a design that puts all the internal pressure and load on a peel strength surface. By adding the intermediate layer 620 with a narrower diameter than the first layer 610, the seal between the first layer 610 and the second layer 630 is reinforced.
  • Packaging
  • One method of achieving the specified oxygen concentration in the reservoir 130 and to create the controlled atmospheric packaging is to (1) assemble dressing, sealing the reservoir with normal atmospheric conditions (about 21% oxygen); (2) place the dressing in a package (e.g., a metallized film package); (3) flush the package with substantially pure oxygen; and (4) sealing the package. In storage, the gas in the reservoir 130 will come to equilibrium with the gas in the package via the permeable film 160. When the package is received by the customer and opened, the gas in the reservoir will achieve about 95-98% oxygen. The materials and dimensions used are determined by taking into account these objectives. The final concentration in the reservoir depends upon the volume and ratios of gases. For example, a dressing containing about 10 cc of air in the reservoir placed in a package which is filled with about 200 cc oxygen will equilibrate at a final oxygen concentration of approximately 96% 202 cc oxygen 210 total cc gas = 96 %
  • FIG. 2 illustrates an exemplary packaging system 200. The packaging system 200 is shown as an exemplary perspective cut-away view to more clearly illustrate the invention. In one embodiment, the packaging system 200 is configured to contain a gas within an enclosed container 210, which is within the packaging system. For example, the different gases contained within the dressing system 100 may include but is not limited to oxygen, carbon dioxide, nitrogen, and/or nitric oxide.
  • The enclosed container 210 may also be configured to hold the dressing system 100 as shown and described corresponding to FIG. 1. Once the enclosed container 210 is sealed, the enclosed container is substantially impermeable; the gas within the enclosed container 210 substantially remains within the enclosed container 210. Further, the enclosed container 210 utilizes controlled atmospheric packaging (CAP) to maintain the environment within the enclosed container 210. In one embodiment, CAP is a package with high barrier properties that contains the desired ratio of gases to preserve the internal environment. The gas within the enclosed container 210 may permeate the dressing system 100 through the permeable film 160.
  • In still other embodiments, a hole may be created in the dressing system (preferably on one side of the dressing, and preferably on the permeable side of the dressing), and the dressing placed in the package. The package is then evacuated which also evacuates the reservoir. The package is then filled with the one or more desired gases (e.g., oxygen) and sealed. Thereafter, the reservoir in the dressing fills with the gases contained in the package. The time it takes for the oxygen to enter the reservoir may be between less than a minute to several hours, and more preferably between about several minutes and several hours. It suffices to say, by the time the packaged dressing is sold, the reservoir contains sufficient amount of the packaged gases to supply a wound or other use. The hole in the dressing is sized so that upon opening of the package and removal/use of the dressing, a negligible amount of oxygen is released from the reservoir prior to application to the intended target area.
  • In some embodiments, to achieve desired gas concentration levels, CAP gas amounts in the package are sufficiently high so as to create a bulky package. For example, packaging for a wound dressing may be inflated with at least oxygen gas, causing the package to expand such that the package is bulky and much larger than the wound dressing. After a period of time sufficient enough to allow the oxygen to penetrate the dressing the remaining gas or a portion of the gas may be removed from the package. This allows the final package to be smaller and thus, shipped and distributed more easily.
  • The packaging system 200 may be utilized to store the dressing system 100 without degrading the gas stored within the reservoir 130 within the dressing system 100 when the gas within the reservoir 130 and the gas within the enclosed container 210 are the same.
  • The packaging system 200 may be utilized to change the concentrations of gases in the dressing system 100. The gas constituents stored within the enclosed container 210, diffuse into the dressing system 100 when the concentration of the gas within the container 210 is higher in concentration compared to the gas within the dressing system 100. Similarly, the gas constituents stored within the dressing system 100, diffuse into the container 210 when the concentration of the gas within the container 210 is lower in concentration compared to the gas within the dressing system 100. The gases may diffuse through the permeable film 160 until the constituents reach equilibrium, the same concentrations on both sides of the permeable film. In other embodiments, gas infusion may be accomplished in a barrier package at a temperature and/or pressure greater than atmosphere in order to hasten or increase the levels of taken up by a device.
  • Another embodiment of the packaging system comprises any of the packaging systems described herein and further comprises a septum, which as defined herein may be a septum, a valve, Luer lock or any resealable opening, through which one or more gases can be introduced into the packaging system, then resealed to prevent gases from escaping. The packaging system may be charged with the one or more gases in the desired ratio on site (e.g., hospital, doctor's office).
  • The flow diagram in FIG. 4 illustrates an exemplary process of utilizing the packaging system 200 according to one embodiment.
  • In Block 410, a gas-retaining object is placed within the packaging system 200. In one embodiment, the gas-retaining object is the dressing system 100. In another embodiment, the gas-retaining object is gas emitting pouch system 300. In yet another embodiment, the gas-retaining object may be any item that is configured to retain and controllably release a gas from the object.
  • In Block 420, the packaging system 200 is flushed with a gas. In one embodiment, the packaging system 200 is flushed with the same gas contained with the gas-retaining object. For example, the dressing system 100 may be pre-filled with oxygen and placed within the packaging system. By flushing the packaging system 200 with oxygen, the packaging system 200 ensures that the dressing system 100 retains the pre-filled oxygen content.
  • In another embodiment, the packaging system 200 is flushed with a different gas than the gas contained with the gas-retaining object. For example, the dressing system 100 may contain air that contains other gases in addition to oxygen and may be placed within the packaging system 200. By flushing the packaging system 200 with pure oxygen, the packaging system 200 diffuses the dressing system 100 with additional oxygen until the gas within the packaging system 200 and the gas within the dressing system 100 have reached an equilibrium.
  • In Block 430, the packaging system 200 is sealed after placing the gas-retaining object within the packaging system 200 and flushing the packaging system 200 with a gas.
  • In Block 440, if the gas within the gas retaining device and the gas within the packaging system 200 differ, then an exchange of gas occurs until an equilibrium is achieved. For example, by using the above example describing a dressing system I 00 that contains air which is sealed within the packaging system 200 flushed with pure oxygen, the oxygen diffuses into within the dressing system 100, while nitrogen diffuses out of the dressing system 100 into the package 200 until an equilibrium is achieved between the gas within the dressing system 100 and the packaging system 200. In this embodiment, the gas may be exchanged through the permeable film 160 (FIG. 1).
  • In Block 450, the packaging system 200 may be opened to remove the gas-retaining object. The packaging system 200 may be utilized to store the gas-retaining object without degrading the gas within the gas-retaining object. In another embodiment, the packaging system 200 may be utilized to infuse the gas-retaining object with a gas.
  • Mechanisms for carrying out the removal of remaining gases (or a portion thereof) from the packaging may include devices such as a rubber septum or a self-sealing material provided for on a wall of the package. As shown in FIG. 9D, located on the interior (or between layers if multiple layers of material are used) the wall 902 of the package includes a self-sealing material 904. The self-sealing material allows a puncture through a wall of the package to self-seal, preferably after excess gas has escaped from the puncture. For example, after pressurization, and after a packaged device has absorbed a specified gas or gases (and may have also absorbed other therapeutic materials), the package is punctured and pressure is applied to the package to force out the remaining materials (e.g., gases and or therapeutic materials) which have not been absorbed by the device. After the package has decreased in size, the puncture device (e.g., a needle) may be removed and the force on the package is released. The puncture hole is then sealed from the flow of the self-sealing material. Alternatively, the package may be vented and re-sealed as shown in FIGS. 9A-9C. Specifically, as shown in FIG. 9A, a puncture device 906 may be used to puncture a wall 908 of the package which contains a gas delivery device 910. As shown, the ends 912 may be heat sealed.
  • FIG. 9B illustrates gas excess gas(es) escaping out of the puncture hole 914 (arrows B), which may be driven by pressure (arrows A) applied to the package. Thereafter, the end of the package may be heat sealed at a location of the puncture 914 which eliminates the puncture/vent from the final package.
  • Alternative to the above (or in addition thereto) the package may include a one-way valve 916 on a wall 918 of the package as shown in FIG. 9E. The valve may comprise one or more flaps 920 which allow one-way travel of gas—i.e., out of the package. Upon the device having absorbed the gas(es) and/or other therapeutic agents, pressure may be applied to the outside of the package which forces the valve 916 open and the excess agent out of the package.
  • Use of a Tissue Dressing System
  • The flow diagram in FIG. 5 illustrates an exemplary process of utilizing the dressing system 100 according to one embodiment. Accordingly, in Block 510, the dressing system 100 is removed from a packaging.
  • In Block 520, the dressing system 100 is adhered to a user. In one embodiment, the dressing system 100 may cover a wound or broken skin of the user. In one embodiment, the dressing system 100 utilizes the adhesive backing 150 to adhere the dressing system 100 to the user.
  • In Block 530, a seal is formed between the dressing system 100 and the user. In one embodiment, the adhesive backing 150 forms the seal between the dressing system 100 and the user.
  • In Block 540, gas is supplied from the dressing system 100 to the user. In one embodiment, the permeable film 160 is positioned over the wound or broken skin of the user and allows the gas from the dressing system 100 to be supplied to wound of the user.
  • In another embodiment, the permeable film 160 may be positioned over intact skin of the user and allows the gas from the dressing system 100 to be supplied to the skin of the user. There are numerous practical applications in supplying oxygen to intact skin such as treating sun or radiation damaged skin, exfoliated skin, dermabraded skin, or providing nourishment to aged skin. There may be a synergistic effect with topical agents as well.
  • In Block 550, the gas within the reservoir 130 of the dressing system 100 may be stored until additional gas is supplied to the user through the permeable film 160.
  • Ophthalmologic Embodiments.
  • Contact Lens Oxygenation. In another group of embodiments, a method and system for oxygenating or re-oxygenating contact lenses between uses is provided. Specifically, these embodiments include taking one or more contact lenses and placing them into a container that may be charged (and/or re-charged) with oxygen (or another specific gas or gases). Accordingly, users may then be able to oxygenate their own contact lenses. The lenses may be inserted into the case, for example, by popping them thru a gentle one way valve, or, alternatively, the lenses may be placed in a contact lens case and the case may then be oxygenated—either by inflating a collapsed case or flushing oxygen thru a rigid case (for example). The rigid case, accordingly, may include a venting mechanism for escaped gas.
  • FIG. 10 illustrates an example of a contact lens case 1000 having a re-sealable port 1002 a and 1002 b, to which oxygen source 1004 can be flowed into. One-way valve vents 1006 a and 1006 b allows gases to flow out of each respective chamber of the contact lens case so as to insure fresh oxygen from oxygen source 1004 is contained in each chamber. These embodiments may, in addition to being used for contact lenses, also be used to oxygenate contacts that are used as “bandage lenses” after photorefractive keratectomy laser surgery for nearsightedness (for example). Keratectomy is a procedure where the outer cell layer of the cornea is removed, resulting in a wound that is a large abrasion on the eye, which is extremely painful to the patient. Accordingly, such bandage lenses are used as a protective covering on the cornea once anesthetic wears off.
  • Oxygen can be supplied a variety of ways to the contact lens case/container: e.g., via compressed oxygen stored in a cylinder or spray-can, or in prefilled, non-pressurized oxygen packages that allow the user to insert the device without leaking oxygen, and then open the package. Moreover, some embodiments of the invention may include contact-lens cases which include a reservoir of oxygen that, release oxygen to the area in which the contact lens is stored.
  • Other Embodiments
  • Still other embodiments of the invention include uses and methods for charging gas carrying media, such as oxygenating oxygen carrier gels, foams or solutions. For example, placing these materials into an impermeable package and filling the package with the predetermined gas, these materials become charged or saturated with gas while inside the package. Whether gases are supplied via a reservoir created between a barrier layer and a gas-permeable layer or through a gas-permeable continuous layer, the one or more gases may be stored in micro- or nano-reservoirs. These multiplicative reversible gas carrying reservoirs may include, for example, micro- or nano-particles, beads, spheres, mems (microelectro-mechanical systems), pigments or liposomes, for delivery to the target area. Further descriptions of such materials (e.g., repirocytes) can be found at:
    • www.foresight.org/Nanomedicine/Respirocytes.html, and
    • www.foresight.org/Nanomedicine/Respirocytes1.html#Sec22.
  • One form of respirocyte includes “molecular sorting rotors” which have been described by Drexler K E. Nanosystems: Molecular Machinery, Manufacturing, and Computation. New York: John Wiley & Sons, 1992. These tiny rotors have binding site “pockets” along their rims that are exposed alternately to the gas source to deliver or infuse gas from or into an interior microchamber. Once the binding site rotates to expose it to the interior chamber, the bound molecules are forcibly ejected by rods thrust outward by the cam surface. This can work equivalently in the reverse direction by ejecting gas after interior chamber has been charged with gas. These theoretical respirocytes can be designed to precisely take on and dispense oxygen and carbon dioxide separately or simultaneously under various conditions). Other reversible oxygen carriers include transport pigments which are conjugated proteins, or proteins complexed with another organic molecule or with one or more metal atoms. Transport pigments contain metal atoms such as Cu2+ or Fe3+. Besides hemoglobin and myoglobin, other natural oxygen carriers include hemocyanin, a blue copper-based pigment found in molluscs and crustaceans and chlorocruorin, a green iron-based pigment found in marine polychaete worms, and different oxides of vanadium. Other reversible oxygen-carriers include cobalt-based porphyrins such as coboglobin (a cobalt-based analog to hemoglobin) and cobaltodihistidine, and other metallic porphyrins, iron-indigo compounds, iridium complexes such as chloro-carbonyl-bis(triphenylphosphine)-iridium, a cobalt/ammonia complex described by (Hearon J Z, Burke D, Schade A L. Physicochemical studies of reversible and irreversible complexes of cobalt, histidine, and molecular oxygen. J Natl Cancer Inst 1949; 9:337-377), zeolite-bound divalent chromium, nonporphyrin lacunar iron complexes, and heme-linked NADPH oxidase.
  • Still other embodiments may include a device which includes a semi-solid, fluid or semi-fluid, gas infused material (i.e., gas being absorbed/adsorbed). Such semi-solid or semi-fluid products may include a gel, an ointment or a foam which is infused with one or more gases. Such materials may be cast on a film, and positioned over a wound or proximate a target where the desired gas(es) is to be provided. Such materials also may, as indicated above, be contained in a reservoir. Gel/foam materials may include but are not limited to hydrogels, acrylic resins, polyethylene glycols (or derivatives or cocktails thereof), polyacrylamide, glcosaminoglycan, polyethylene oxide, carboxymethyl-chitin hydrogel, poly(vinyl alcohol), nitric oxide releasing hydrogels, chitosan hydrogel, hydrogen peroxide gels, wound healing gels, bioerodible HEMA hydrogels, drug delivery gels (see for example Cox, Charles, “Treatment Options Gel With Innovative Drug Delivery Systems”, Drug Delivery Technology (http://www.drugdeliverytech.com/cgi-bin/articles.cgi?idArticle=55); Eisenbud, D et al., “Hydrogel Wound Dressings: where do we stand in 2003?”, pp. 52-57, Ostomy Wound Manage, October 2003; Chiellini, Federica et al., “Bioerodible hydrogels based on 2-hydroxyethyl methacrylate: Synthesis and characterization”, Journal of Applied Polymer Science, ISSN 0021-8995, Vol. 85, pp. 2729-2741 (2002). Each of the foregoing references is incorporated herein by reference in its entirety.
  • Materials infused with one or more predetermined gases, whether micro/nano particles or beads, gels, foams or combination thereof may also be bio-compatible and/or bio-resorbable materials. The term “bioresorbable materials” refers to a group of materials that have been shown to clinically resorb in living tissue (e.g., the human body), and include such products as sutures, dermal fillers and bone fillers (for example). According, such gas-delivery devices according to some embodiments of the present invention, when implanted into tissue (e.g., bone, cartilage, subdermal fat), biodegrade as they release (or when upon releasing a majority of) its stored gas such as oxygen or nitric oxide. Accordingly, such bioresorbable materials can include calcium phosphates, hydroxyapatite, apatites, calcium sulfates, bioresorbable polymers, collagen, gelatin, and bioactive glass. Calcium phosphates include alpha-tri-calcium phosphate and beta-tri-calcium phosphate.
  • Still other embodiments of the invention include uses and methods for storing and/or preserving oxygen media, tissue, and/or cells (e.g., red-blood cells), as well as uses and methods for oxygenating oxygen carrier solutions. Such solutions may include perfluorocarbons, polyhemoglobins, molecularly modified hemoglobin, and oxygenated Krebs solution.
  • Still other embodiments of the invention include methods to oxygenate scaffolds, tissues, artificial skin that may contain fibrinogen, collagen, hemoglobin, myoglobin, or other reversible oxygen binding agents for use as wound or aesthetic dressings. By placing these materials into a package and filling the package with oxygen, these materials become saturated with oxygen within the package and then upon application to the tissue, release that oxygen over time depending on the design and local oxygen demand.
  • The foregoing descriptions of specific embodiments of the invention have been presented for purposes of illustration and description. They are not intended to be exhaustive or to limit the invention to the precise embodiments disclosed, and naturally many modifications and variations are possible in light of the above teaching. The embodiments were chosen and described in order to explain the principles of the invention and its practical application, to thereby enable others skilled in the art to best utilize the invention and various embodiments with various modifications as are suited to the particular use contemplated.

Claims (50)

1. A gas delivery device for supplying one or more predetermined gases to a target environment, the device comprising a reservoir, a gas diffusion portion for communicating gas from the reservoir and one or more predetermined gases at concentrations other than ambient levels are contained within the reservoir, wherein the device does not generate gas.
2. The device according to claim 1, wherein the device may be packaged prior to use with the one or more predetermined gases.
3. The device according to claim 1, wherein the reservoir is substantially enveloped by a layer of material, and wherein the layer of material is formed in a shape selected from the group consisting of: a tube, a balloon, a ring, and a pouch.
4. The device according to claim 1, wherein the reservoir is substantially enveloped by a layer of material, and wherein the layer of material is formed into all or a portion of a contact lens.
5. The device according to claim 1, wherein the reservoir comprises a plurality of particles infused with the one or more predetermined gases at concentrations greater than atmospheric.
6. The device according to claim 5, wherein the particles are selected from the group consisting of reversible gas carriers such as nanoparticles, beads, spheres, bubbles, pigments or encapsulations, liposomes, oxygen transport pigments, hemoglobin derivatives, derivatives of perflurocarbon and combinations thereof.
7. The device of claim 1, wherein the gas diffusion portion comprises at least a first portion of a wall of the reservoir.
8. The device of claim 7, wherein the at least a portion of the wall is selected from the group consisting of: polyurethane, silicone, polyvinylchloride, ethylene vinyl alcohol and polyolefins.
9. The device of claim 7, wherein the at least a first portion of the wall is porous and/or perforated.
10. The device of claim 9, wherein the at least a first portion of the wall is porous and/or perforated in a manner sufficient to allow non-gas entities to pass through.
11. The device of claim 10, wherein the non-gas entities comprise nutritional or therapeutic agents
12. The device of claim 1, wherein the one or more predetermined gases contained in the reservoir is controllably released to the target environment through the gas diffusion portion.
13. The device of claim 1, further comprising an absorbent layer.
14. The device of claim 1, wherein a compliant porous insert is contained within the reservoir.
15. The device of claim 14, wherein the compliant porous insert is comprised of a sponge-like and/or porous material.
16. The device of claim 14, wherein an absorbent layer is incorporated into the compliant porous insert.
17. The device of claim 14, wherein the compliant porous insert substantially fills the reservoir.
18. The device of claim 14, wherein a compliant porous insert is incorporated in the absorbent layer
19. The device of claim 1, wherein the one or more predetermined gases is selected from the group consisting of: oxygen, nitrogen, carbon dioxide and nitric oxide.
20. The device of claim 1, wherein the reservoir further contains a biologically beneficial agent.
21. The device of claim 20, wherein the biologically beneficial agent is selected from the group consisting of: a drug, a mineral, a nutrient, an amino acid, a pH modifier, an anti-microbial, a growth factor and an enzyme.
22. The device of claim 20, wherein the biologically beneficial agent is contained in microcapsules provided for on at least one of the layers.
23. The device of claim 20, wherein the biologically beneficial agent is contained in a gel matrix external to the reservoir.
24. The device of claim 1, wherein a wall of the reservoir comprises a plurality of spaced apart ribs.
25. The device of claim 1, further comprising a substantially gas-impermeable enclosed container containing the one or more second predetermined gases and the device.
26. The device according to claim 1, wherein the one or more predetermined gases are contained in a gas-infused gel provided external to the reservoir.
27. The device according to claim 1, wherein the one or more predetermined gases are contained in a gas-infused foam provided external to the reservoir.
28. The device according to claim 1, further comprising a septum.
29. A gas delivery device for supplying one or more predetermined gases to a target environment, comprising a reservoir, a gas diffusion portion for communicating gas from the reservoir and one or more predetermined gases at concentrations other than ambient contained within the reservoir, wherein the device does not generate gas and may be packaged prior to use with the one or more predetermined gases.
30. The device according to claim 29, wherein a preset volume of the one or more predetermined gases are contained within the reservoir.
31. The device according to claim 29, wherein the one or more predetermined gases are included within the reservoir at about atmospheric pressure.
32. The device according to claim 29, wherein the gas delivery device is packaged prior to use at about atmospheric pressure.
33. The device according to any of claim 29, wherein the one or more predetermined gases is selected from the group consisting of oxygen, nitrogen, carbon-dioxide and nitric oxide.
34. The device according to claim 29, further comprising a substantially gas-impermeable enclosed package for containing the gas delivery device prior to use.
35. A gas delivery device for supplying one or more predetermined gases to a target environment, the device comprising a reservoir, a gas diffusion portion for communicating gas from the reservoir, one or more predetermined gases at concentrations greater than atmospheric contained within the reservoir, and a pressure release port, wherein the device does not generate gas.
36. The device according to claim 35, wherein the pressure release port comprises either a one-way or a two-way valve.
37. A pre-packaged gas-infused material for supplying one or more predetermined gases to a target environment, the material comprising one or both of a gas infused gel and a gas-infused foam.
38. The material according to claim 37, wherein the gel and/or foam gel is selected from the group consisting of: a hydrogel, an acrylic resin, polyethylene glycol, polyacrylamide, glucosaminoglycan, polyethylene oxide, and derivative and combinations of the foregoing.
39. A method of packaging a gas delivery device comprising:
providing a gas delivery device for supplying one or more predetermined gases to a target environment, the device comprising a reservoir, a gas diffusion portion for communicating gas from the reservoir and one or more predetermined gases at concentrations greater than atmospheric contained within the reservoir, wherein the device does not generate gas;
placing the gas delivery device into a package for containing the gas delivery device prior to use, wherein the package capable of being substantially gas-impermeable when sealed, and wherein the package includes a self-sealing material;
pressurizing the package with the one or more predetermined gases immediately prior to or substantially concurrently with the sealing of the package;
puncturing the package after a predetermined period of time has elapsed after sealing the package, and
applying a pressure to the outside of the package to release excess one or more predetermined gases.
40. The method according to claim 40, wherein after the pressure to the outside of the package is removed, the self-sealing material seals the puncture.
41. The method according to claim 40, wherein the excess one or more predetermined gases are released through a valve.
42. The method according to claim 41, wherein the valve comprises a one-way valve mechanism.
43. The method f according to claim 42, wherein the one way valve releases the excess one or more predetermined gases upon the pressure in the package reaching a predetermined level.
44. The method according to claim 40, wherein immediately prior to removing the pressure applied to the outside of the package to release the excess one or more predetermined gases, the method further includes re-sealing the package.
45. The method according to claim 44, wherein re-sealing the package comprises heat-sealing.
46. A contact lens case comprising:
a container holding at least one contact lens and also for optionally holding contact lens solution; and
one or more predetermined gases at concentrations greater than atmospheric included within the reservoir.
47. A contact lens oxygenation system comprising:
a container for holding a contact lens;
an inlet for supplying a flow of oxygen to the container;
a supply of oxygen capable of providing a flow of oxygen to the inlet; and
an one-way valved outlet for releasing excess pressure from the container.
48. A method for oxygenating a contact lens comprising:
providing at least one contact lens container for holding at least one contact lens in a sealed state;
positioning at least one contact lens inside the at least one contact lens container;
providing oxygen to the inside of the at least one contact lens container in concentrations greater than atmospheric.
49. The method according to claim 48, wherein providing oxygen comprises establishing a flow of oxygen into the container.
50. The method according to claim 48, wherein the container includes a one-way valve such that upon the flow of oxygen being established excess pressure is released from within the container upon the pressure reaching a predetermined level.
US11/356,929 2003-06-18 2006-02-16 Method and apparatus for supplying gas to an area Abandoned US20060200100A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US11/356,929 US20060200100A1 (en) 2003-06-18 2006-02-16 Method and apparatus for supplying gas to an area
US11/485,513 US8166731B2 (en) 2003-06-18 2006-07-12 Method and apparatus for supplying gas to an area
US11/899,394 US7762045B2 (en) 2003-06-18 2007-09-04 Method and apparatus for supplying gas to an area
US13/459,680 US8900209B2 (en) 2003-06-18 2012-04-30 Method and apparatus for supplying gas to an area

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US47974503P 2003-06-18 2003-06-18
US10/781,965 US7014630B2 (en) 2003-06-18 2004-02-18 Tissue dressing having gas reservoir
US65403705P 2005-02-17 2005-02-17
US66201905P 2005-03-14 2005-03-14
US71179605P 2005-08-26 2005-08-26
US11/356,929 US20060200100A1 (en) 2003-06-18 2006-02-16 Method and apparatus for supplying gas to an area

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
US10/781,965 Continuation-In-Part US7014630B2 (en) 2003-06-18 2004-02-18 Tissue dressing having gas reservoir
US11/183,284 Continuation-In-Part US7263814B2 (en) 2003-06-18 2005-07-15 Method and apparatus for supplying gas to an area

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US11/485,513 Division US8166731B2 (en) 2003-06-18 2006-07-12 Method and apparatus for supplying gas to an area
US11/899,394 Division US7762045B2 (en) 2003-06-18 2007-09-04 Method and apparatus for supplying gas to an area

Publications (1)

Publication Number Publication Date
US20060200100A1 true US20060200100A1 (en) 2006-09-07

Family

ID=37392852

Family Applications (3)

Application Number Title Priority Date Filing Date
US11/356,929 Abandoned US20060200100A1 (en) 2003-06-18 2006-02-16 Method and apparatus for supplying gas to an area
US11/485,513 Active - Reinstated 2026-09-08 US8166731B2 (en) 2003-06-18 2006-07-12 Method and apparatus for supplying gas to an area
US13/459,680 Expired - Fee Related US8900209B2 (en) 2003-06-18 2012-04-30 Method and apparatus for supplying gas to an area

Family Applications After (2)

Application Number Title Priority Date Filing Date
US11/485,513 Active - Reinstated 2026-09-08 US8166731B2 (en) 2003-06-18 2006-07-12 Method and apparatus for supplying gas to an area
US13/459,680 Expired - Fee Related US8900209B2 (en) 2003-06-18 2012-04-30 Method and apparatus for supplying gas to an area

Country Status (1)

Country Link
US (3) US20060200100A1 (en)

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100038280A1 (en) * 2008-08-15 2010-02-18 Franklin Amie B Hermetically Sealed Package for A Therapeutic Diffusion Device
WO2010027632A2 (en) * 2008-08-15 2010-03-11 Oxyband Technologies, Inc. Multiple cell therapeutic diffusion device
EP2519297A2 (en) * 2009-12-31 2012-11-07 Ohio University Systems and methods for promoting wound healing
US20150128949A1 (en) * 2011-02-11 2015-05-14 Koninklijke Philips Patient interface device having headgear providing integrated gas flow and delivery
USD746478S1 (en) * 2013-07-05 2015-12-29 Mölnlycke Health Care Ab Wound filler
USD783843S1 (en) 2013-07-05 2017-04-11 Mölnlycke Health Care Ab Wound filler
US20180203253A1 (en) * 2016-04-14 2018-07-19 Johnson & Johnson Vision Care, Inc. Methods and apparatus to enhance oxygen concentrations for ophthalmic devices
US20180203254A1 (en) * 2016-04-14 2018-07-19 Johnson & Johnson Vision Care, Inc. Methods and apparatus to enhance oxygen concentrations for advanced ophthalmic devices
US10272175B2 (en) 2013-11-26 2019-04-30 Avent, Inc. Foams for oxygen delivery to wounds
US10293073B2 (en) 2014-08-29 2019-05-21 Avent, Inc. Moisture management for wound care
US10327956B2 (en) 2014-01-24 2019-06-25 Avent, Inc. Traumatic wound dressing system with wrap
WO2019139829A1 (en) * 2018-01-10 2019-07-18 Kci Licensing, Inc. Negative pressure wound therapy dressings with local oxygen generation for topical wound therapy and related methods
US10568771B2 (en) 2014-01-24 2020-02-25 Avent, Inc. Traumatic wound dressing system with conformal cover
US11090409B2 (en) * 2010-04-09 2021-08-17 Kci Licensing, Inc. Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds
US11141523B2 (en) 2017-10-26 2021-10-12 Kci Licensing, Inc. Wound dressings and systems for effluent management of topical wound therapy and related methods
US11547611B2 (en) 2017-09-22 2023-01-10 Kci Licensing, Inc. Wound dressings and systems with high-flow therapeutic gas sources for topical wound therapy and related methods
EP4146323A1 (en) * 2020-05-04 2023-03-15 Fisher & Paykel Healthcare Limited Wound edge diffuser

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060200100A1 (en) * 2003-06-18 2006-09-07 Rosati Coni F Method and apparatus for supplying gas to an area
US20090159176A1 (en) * 2007-12-21 2009-06-25 Palo Alto Research Center Incorporated Sealing method for containing materials
JP6068124B2 (en) * 2012-12-17 2017-01-25 昭和電工パッケージング株式会社 Exterior material for air secondary battery and air secondary battery
US10463760B2 (en) 2017-10-31 2019-11-05 InMEDBio, LLC Absorbent, breathable and pathogen blocking/killing wound care dressing and fabrication thereof
EP3886879A4 (en) 2018-11-30 2022-12-07 Cellphire Inc. Platelets as delivery agents
US11529587B2 (en) 2019-05-03 2022-12-20 Cellphire, Inc. Materials and methods for producing blood products
EP4013496A4 (en) 2019-08-16 2023-10-18 Cellphire Inc. Thrombosomes as an antiplatelet agent reversal agent
US20210308066A1 (en) 2020-02-04 2021-10-07 Cellphire, Inc. Anti-fibrinolytic loaded platelets
US20220288269A1 (en) * 2019-08-26 2022-09-15 Menicon Co., Ltd. Ocular device case and refill container used for the ocular device case

Citations (97)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2987439A (en) * 1958-01-07 1961-06-06 William Cooper & Nephews Inc Method of applying an aerosol to the eye
US3598123A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3610238A (en) * 1970-04-28 1971-10-05 Us Health Education & Welfare Wound infection prevention device
US3742951A (en) * 1971-08-09 1973-07-03 Alza Corp Bandage for controlled release of vasodilators
US4003371A (en) * 1975-02-13 1977-01-18 Fischer Boguslav Low pressure hyperbaric chamber
US4022204A (en) * 1974-11-21 1977-05-10 Warner-Lambert Company Dimensionally stable shaped eye bandages
US4055672A (en) * 1972-04-10 1977-10-25 Standard Packaging Corporation Controlled atmosphere package
US4201211A (en) * 1977-07-12 1980-05-06 Alza Corporation Therapeutic system for administering clonidine transdermally
US4211223A (en) * 1979-04-18 1980-07-08 Lopiano Rocco W Pulsed oxygen chamber
US4224941A (en) * 1978-11-15 1980-09-30 Stivala Oscar G Hyperbaric treatment apparatus
US4296743A (en) * 1979-05-24 1981-10-27 Lasley Robert A Hyperbaric oxygen chamber with fluidic control
US4328799A (en) * 1980-06-13 1982-05-11 Lopiano Rocco W Sacral topical hyperbaric oxygen chambers
US4379454A (en) * 1981-02-17 1983-04-12 Alza Corporation Dosage for coadministering drug and percutaneous absorption enhancer
US4432354A (en) * 1979-05-24 1984-02-21 Lasley Robert A Hyperbaric oxygen chamber with fluidic control
US4460368A (en) * 1981-10-29 1984-07-17 Almedco, Inc. Trans-dermal medication system
US4474571A (en) * 1982-09-29 1984-10-02 Lasley Robert A Portable topical hyperbaric chamber assembly
US4497406A (en) * 1982-05-06 1985-02-05 Terumo Corporation Package for storage of medical container
US4548824A (en) * 1983-05-02 1985-10-22 Pakor, Inc. Package for storing perishable products in a reduced air atmosphere
US4608041A (en) * 1981-10-14 1986-08-26 Frese Nielsen Device for treatment of wounds in body tissue of patients by exposure to jets of gas
US4624656A (en) * 1983-07-25 1986-11-25 Hospitak, Inc. Hyperbaric gas treatment device
US4747841A (en) * 1985-03-19 1988-05-31 Yasuro Kuratomi Methods and instruments of moxibustion
US4750610A (en) * 1986-12-29 1988-06-14 Ryder International Corporation Lens case with pressure sensitive venting system
US4764382A (en) * 1984-11-15 1988-08-16 Hercon Laboratories Corporation Device for controlled release drug delivery
US4779398A (en) * 1987-02-06 1988-10-25 W. R. Grace & Co.-Conn., Cryovac Div. Method and apparatus for making gas flushed packages
US4801291A (en) * 1987-11-18 1989-01-31 Loori Phillip E Portable topical hyperbaric apparatus
US4813210A (en) * 1985-09-27 1989-03-21 Nissho Corporation Radiation-sterilized, packaged medical device
US4837027A (en) * 1987-11-09 1989-06-06 Alza Corporation Transdermal drug delivery device
US4839345A (en) * 1985-03-09 1989-06-13 Nippon Oil And Fats Co., Ltd. Hydrated adhesive gel and method for preparing the same
US4842875A (en) * 1986-10-06 1989-06-27 Hercules Incorporated Controlled atmosphere package
US4875483A (en) * 1983-10-17 1989-10-24 Telectronics, N.V. Implantable cardiac pacer with programmable antitachycardia mechanisms
US4875473A (en) * 1986-04-03 1989-10-24 Bioderm, Inc. Multi-layer wound dressing having oxygen permeable and oxygen impermeable layers
US4895729A (en) * 1987-03-31 1990-01-23 University Of British Columbia Preservation of cut and segmented fresh fruit pieces
US4906463A (en) * 1986-12-22 1990-03-06 Cygnus Research Corporation Transdermal drug-delivery composition
US4909244A (en) * 1986-11-26 1990-03-20 The Kendall Company Hydrogel wound dressing
US4919955A (en) * 1987-09-08 1990-04-24 Mitchell Jerry L Method for packaging perishable products
US4969881A (en) * 1989-11-06 1990-11-13 Connecticut Artcraft Corp. Disposable hyperbaric oxygen dressing
US5008110A (en) * 1988-11-10 1991-04-16 The Procter & Gamble Company Storage-stable transdermal patch
US5014494A (en) * 1988-09-27 1991-05-14 Sherwood Medical Company Method of sterilizing medical articles
US5029579A (en) * 1989-01-13 1991-07-09 Ballard Medical Products Hyperbaric oxygenation apparatus and methods
US5149538A (en) * 1991-06-14 1992-09-22 Warner-Lambert Company Misuse-resistive transdermal opioid dosage form
US5154697A (en) * 1991-04-02 1992-10-13 Topox, Inc. Collapsible topical hyperbaric apparatus
US5308887A (en) * 1991-05-23 1994-05-03 Minnesota Mining & Manufacturing Company Pressure-sensitive adhesives
US5336209A (en) * 1990-04-06 1994-08-09 Porzilli Louis B Multi-function wound protection bandage and medicant delivery system with simultaneous variable oxygenation
US5354790A (en) * 1989-03-30 1994-10-11 Nepera, Inc. Methods for the preparation of non-stringy adhesive hydrophilic gels
US5466465A (en) * 1993-12-30 1995-11-14 Harrogate Holdings, Limited Transdermal drug delivery system
US5481852A (en) * 1987-09-08 1996-01-09 Pakor, Inc. Method and apparatus to promote gas exchange from a sealed receptacle
US5487889A (en) * 1992-06-03 1996-01-30 The Metrohealth System Bandage for continuous application of biologicals
US5549908A (en) * 1993-05-20 1996-08-27 The University Of Akron Hydrolytically labile microspheres of polysaccharide crosslinked with cyanogen halide and their application in wound dressings
US5578022A (en) * 1995-04-12 1996-11-26 Scherson; Daniel A. Oxygen producing bandage and method
US5605664A (en) * 1994-07-13 1997-02-25 I-Stat Corporation Methods and apparatus for rapid equilibration of dissolved gas composition
US5614212A (en) * 1992-04-08 1997-03-25 International Medical Associates, Inc. Method of transdermally administering high molecular weight drugs with a polymer skin enhancer
US5662625A (en) * 1996-05-06 1997-09-02 Gwr Medical, L.L.P. Pressure controllable hyperbaric device
US5707499A (en) * 1995-10-06 1998-01-13 Ceramatec, Inc. Storage-stable, fluid dispensing device using a hydrogen gas generator
US5733572A (en) * 1989-12-22 1998-03-31 Imarx Pharmaceutical Corp. Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
US5762678A (en) * 1996-08-05 1998-06-09 Hiles; Maurice Conversion of cellulosic waste to a soil improvement complex
US5780048A (en) * 1997-03-20 1998-07-14 Lee; Chung Chih First aid bandage dressing system and method of application thereof
US5788682A (en) * 1995-04-28 1998-08-04 Maget; Henri J.R. Apparatus and method for controlling oxygen concentration in the vicinity of a wound
US5792090A (en) * 1995-06-15 1998-08-11 Ladin; Daniel Oxygen generating wound dressing
US5827530A (en) * 1996-02-05 1998-10-27 Reed, Jr.; Fred Dewitt Fillable patch for dermal or transdermal delivery
US5865722A (en) * 1997-04-04 1999-02-02 Numotech, Incorporated Shape-adaptable topical hyperbaric oxygen chamber
US5901848A (en) * 1993-05-20 1999-05-11 Worlds Class Packaging Systems, Inc. Plural atmosphere package
US5916615A (en) * 1997-06-18 1999-06-29 W. R. Grace & Co.-Conn. Case-ready packages having smooth, gas-permeable substrates on the bottoms thereof to reduce or prevent discoloration when placed in a stack
US5948457A (en) * 1996-04-03 1999-09-07 Tenneco Packaging Inc. Modified atmosphere package
US5964721A (en) * 1995-02-21 1999-10-12 Augustine Medical, Inc. Wound covering
US6073759A (en) * 1997-04-10 2000-06-13 Johns Hopkins University Pre-filled package containing unit dose of medical gas and method of making same
US6074871A (en) * 1989-10-31 2000-06-13 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Cell-culture reactor having a porous organic polymer membrane
US6113922A (en) * 1998-11-13 2000-09-05 Swenson; Russell H. Compositions expressing a pressure of carbon dioxide for improved healing of wounds
US6210725B1 (en) * 1998-05-08 2001-04-03 Tres Fresh, Llc Method for creating modified atmosphere packaging
US6238677B1 (en) * 1998-08-18 2001-05-29 The United States Of America As Represented By The Secretary Of Agriculture Starch microcapsules for delivery of active agents
US6248380B1 (en) * 1995-06-06 2001-06-19 Cryovac, Inc. Package having a dual-film lid comprising a gas-impermeable film and a delaminatable, gas-permeable film
US6251344B1 (en) * 1997-06-27 2001-06-26 Quantum Group, Inc. Air quality chamber: relative humidity and contamination controlled systems
US6256905B1 (en) * 1999-02-12 2001-07-10 Galen White Controlled atmosphere shipping/storage system and method
US6284941B1 (en) * 1999-03-09 2001-09-04 Craig M. Cox Bandage having a scar treatment pad for scar management and scar repair
US20010020146A1 (en) * 1999-08-18 2001-09-06 Satterfield Elaine T. Skin treatment apparatus and method
US20010029956A1 (en) * 1991-11-14 2001-10-18 Argenta Louis C. Wound treatment employing reduced pressure
US6342261B1 (en) * 1992-04-03 2002-01-29 American Air Liquide Method of preserving foods using noble gases
US6432077B1 (en) * 2000-12-26 2002-08-13 Sensormedics Corporation Device and method for treatment of surface infections with nitric oxide
US6451590B1 (en) * 2001-02-01 2002-09-17 Clemson University Apparatus and method for propagating plants
US6458109B1 (en) * 1998-08-07 2002-10-01 Hill-Rom Services, Inc. Wound treatment apparatus
US6465708B1 (en) * 1992-06-19 2002-10-15 Augustine Medical, Inc. Covering
US6465709B1 (en) * 1999-07-08 2002-10-15 Johnson & Johnson Consumer Companies, Inc. Exothermic bandage
US6471685B1 (en) * 2000-05-18 2002-10-29 David James Johnson Medical dressing assembly and associated method of using the same
US6548132B1 (en) * 1998-07-23 2003-04-15 Landec Corporation Packaging biological materials
US6565936B1 (en) * 1998-11-03 2003-05-20 Mitsubishi Polyester Film Gmbh Film laminate comprising a biaxially oriented polyester film with high oxygen barrier, its use and a process for its production
US20030167556A1 (en) * 2002-03-05 2003-09-11 Consumers Choice Systems, Inc. Methods and devices for transdermal delivery of anti-aging compounds for treatment and prevention of facial or neck skin aging
US20030190367A1 (en) * 2002-04-05 2003-10-09 David Balding Oxygen enriched implant for orthopedic wounds and method of packaging and use
US6683747B2 (en) * 2001-11-02 2004-01-27 Seagate Technology Llc Internal disc drive gas reservoir
US20040054338A1 (en) * 2002-09-13 2004-03-18 Farhad Bybordi Closed wound drainage system
US20040057906A1 (en) * 2002-09-24 2004-03-25 Li-Chien Hsu Perfluorocarbon emulsions with non-fluorinated surfactants
US20040116770A1 (en) * 2000-10-17 2004-06-17 O'connor Michael Controlled environment device
US6767342B1 (en) * 2001-04-23 2004-07-27 Evelyna D. Cantwell Oxygen bandage system
US6877601B1 (en) * 1998-10-29 2005-04-12 Tres Fresh L.L.C. Packaging system for extending the shelf life of moisture-containing foods
US20050112245A1 (en) * 2001-07-25 2005-05-26 Delduca Gary R. Modified atmospheric package
US7033823B2 (en) * 2002-01-31 2006-04-25 Cesco Bioengineering, Inc. Cell-cultivating device
US20060111657A1 (en) * 2002-09-27 2006-05-25 Deborah Addison Wound treatment device
US20060142684A1 (en) * 2003-04-11 2006-06-29 Shanbrom Technologies, Llc Oxygen releasing material
US7964766B2 (en) * 2003-10-28 2011-06-21 Smith & Nephew Plc Wound cleansing apparatus in-situ

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ195962A (en) * 1980-01-16 1984-11-09 Metal Box Co Ltd Vacuum packing a product in a rigid container so as to leave no headspace
US4969869A (en) * 1987-07-09 1990-11-13 Burgin Kermit H Pillow construction and medication dispenser
US4890637A (en) * 1988-12-12 1990-01-02 Flavorcoffee Co. Inc. One way valve
US5228271A (en) * 1992-05-28 1993-07-20 Medivators, Inc. Method and apparatus for compacting soft goods
US5374243A (en) * 1993-07-06 1994-12-20 Alpha Therapeutic Corporation Oxygen permeable bag containing oxygen-transporting perfluorochemical for providing oxygen internally to mammals
US5411496A (en) * 1994-03-01 1995-05-02 Homa; Joseph Ostomy pouch containing breakable bubbles containing a deodorizer
US5478310A (en) * 1994-03-23 1995-12-26 Dyson-Cantwell; Evelyna Disposable hyperbaric oxygen chamber
GB9515807D0 (en) * 1995-08-02 1995-10-04 Cantwell Evelyna D Topical hyperbaric bandage
US5810795A (en) * 1996-05-13 1998-09-22 Westwood; Joseph R. Hyperbaric device with secondary pressure zone
US6023915A (en) * 1998-10-29 2000-02-15 Colombo Edward A Modified atmosphere packaging method
US6051263A (en) * 1999-03-31 2000-04-18 World Class Packaging Systems, Inc. Ventable food package
US6942834B2 (en) * 1999-06-01 2005-09-13 Jose Gutman System and method for ozone containing packaging for sanitizing application
US7762045B2 (en) * 2003-06-18 2010-07-27 Oxyband Technologies, Inc. Method and apparatus for supplying gas to an area
US20060200100A1 (en) * 2003-06-18 2006-09-07 Rosati Coni F Method and apparatus for supplying gas to an area
US7014630B2 (en) * 2003-06-18 2006-03-21 Oxyband Technologies, Inc. Tissue dressing having gas reservoir

Patent Citations (101)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2987439A (en) * 1958-01-07 1961-06-06 William Cooper & Nephews Inc Method of applying an aerosol to the eye
US3598123A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3610238A (en) * 1970-04-28 1971-10-05 Us Health Education & Welfare Wound infection prevention device
US3742951B1 (en) * 1971-08-09 1982-11-23
US3742951A (en) * 1971-08-09 1973-07-03 Alza Corp Bandage for controlled release of vasodilators
US4055672A (en) * 1972-04-10 1977-10-25 Standard Packaging Corporation Controlled atmosphere package
US4022204A (en) * 1974-11-21 1977-05-10 Warner-Lambert Company Dimensionally stable shaped eye bandages
US4003371A (en) * 1975-02-13 1977-01-18 Fischer Boguslav Low pressure hyperbaric chamber
US4201211A (en) * 1977-07-12 1980-05-06 Alza Corporation Therapeutic system for administering clonidine transdermally
US4224941A (en) * 1978-11-15 1980-09-30 Stivala Oscar G Hyperbaric treatment apparatus
US4211223A (en) * 1979-04-18 1980-07-08 Lopiano Rocco W Pulsed oxygen chamber
US4296743A (en) * 1979-05-24 1981-10-27 Lasley Robert A Hyperbaric oxygen chamber with fluidic control
US4432354A (en) * 1979-05-24 1984-02-21 Lasley Robert A Hyperbaric oxygen chamber with fluidic control
US4328799A (en) * 1980-06-13 1982-05-11 Lopiano Rocco W Sacral topical hyperbaric oxygen chambers
US4379454A (en) * 1981-02-17 1983-04-12 Alza Corporation Dosage for coadministering drug and percutaneous absorption enhancer
US4608041A (en) * 1981-10-14 1986-08-26 Frese Nielsen Device for treatment of wounds in body tissue of patients by exposure to jets of gas
US4460368A (en) * 1981-10-29 1984-07-17 Almedco, Inc. Trans-dermal medication system
US4497406A (en) * 1982-05-06 1985-02-05 Terumo Corporation Package for storage of medical container
US4474571A (en) * 1982-09-29 1984-10-02 Lasley Robert A Portable topical hyperbaric chamber assembly
US4548824A (en) * 1983-05-02 1985-10-22 Pakor, Inc. Package for storing perishable products in a reduced air atmosphere
US4624656A (en) * 1983-07-25 1986-11-25 Hospitak, Inc. Hyperbaric gas treatment device
US4875483A (en) * 1983-10-17 1989-10-24 Telectronics, N.V. Implantable cardiac pacer with programmable antitachycardia mechanisms
US4764382A (en) * 1984-11-15 1988-08-16 Hercon Laboratories Corporation Device for controlled release drug delivery
US4839345A (en) * 1985-03-09 1989-06-13 Nippon Oil And Fats Co., Ltd. Hydrated adhesive gel and method for preparing the same
US4747841A (en) * 1985-03-19 1988-05-31 Yasuro Kuratomi Methods and instruments of moxibustion
US4813210A (en) * 1985-09-27 1989-03-21 Nissho Corporation Radiation-sterilized, packaged medical device
US4875473A (en) * 1986-04-03 1989-10-24 Bioderm, Inc. Multi-layer wound dressing having oxygen permeable and oxygen impermeable layers
US4842875A (en) * 1986-10-06 1989-06-27 Hercules Incorporated Controlled atmosphere package
US4909244A (en) * 1986-11-26 1990-03-20 The Kendall Company Hydrogel wound dressing
US4909244B1 (en) * 1986-11-26 1994-07-05 Kendall & Co Hydrogel wound dressing
US4906463A (en) * 1986-12-22 1990-03-06 Cygnus Research Corporation Transdermal drug-delivery composition
US4750610A (en) * 1986-12-29 1988-06-14 Ryder International Corporation Lens case with pressure sensitive venting system
US4779398A (en) * 1987-02-06 1988-10-25 W. R. Grace & Co.-Conn., Cryovac Div. Method and apparatus for making gas flushed packages
US4895729A (en) * 1987-03-31 1990-01-23 University Of British Columbia Preservation of cut and segmented fresh fruit pieces
US4919955A (en) * 1987-09-08 1990-04-24 Mitchell Jerry L Method for packaging perishable products
US5481852A (en) * 1987-09-08 1996-01-09 Pakor, Inc. Method and apparatus to promote gas exchange from a sealed receptacle
US4837027A (en) * 1987-11-09 1989-06-06 Alza Corporation Transdermal drug delivery device
US4801291A (en) * 1987-11-18 1989-01-31 Loori Phillip E Portable topical hyperbaric apparatus
US5014494A (en) * 1988-09-27 1991-05-14 Sherwood Medical Company Method of sterilizing medical articles
US5008110A (en) * 1988-11-10 1991-04-16 The Procter & Gamble Company Storage-stable transdermal patch
US5029579A (en) * 1989-01-13 1991-07-09 Ballard Medical Products Hyperbaric oxygenation apparatus and methods
US5354790A (en) * 1989-03-30 1994-10-11 Nepera, Inc. Methods for the preparation of non-stringy adhesive hydrophilic gels
US6074871A (en) * 1989-10-31 2000-06-13 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Cell-culture reactor having a porous organic polymer membrane
US4969881A (en) * 1989-11-06 1990-11-13 Connecticut Artcraft Corp. Disposable hyperbaric oxygen dressing
US5733572A (en) * 1989-12-22 1998-03-31 Imarx Pharmaceutical Corp. Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
US5336209A (en) * 1990-04-06 1994-08-09 Porzilli Louis B Multi-function wound protection bandage and medicant delivery system with simultaneous variable oxygenation
US5154697A (en) * 1991-04-02 1992-10-13 Topox, Inc. Collapsible topical hyperbaric apparatus
US5308887A (en) * 1991-05-23 1994-05-03 Minnesota Mining & Manufacturing Company Pressure-sensitive adhesives
US5149538A (en) * 1991-06-14 1992-09-22 Warner-Lambert Company Misuse-resistive transdermal opioid dosage form
US20010029956A1 (en) * 1991-11-14 2001-10-18 Argenta Louis C. Wound treatment employing reduced pressure
US6342261B1 (en) * 1992-04-03 2002-01-29 American Air Liquide Method of preserving foods using noble gases
US5614212A (en) * 1992-04-08 1997-03-25 International Medical Associates, Inc. Method of transdermally administering high molecular weight drugs with a polymer skin enhancer
US5487889A (en) * 1992-06-03 1996-01-30 The Metrohealth System Bandage for continuous application of biologicals
US6465708B1 (en) * 1992-06-19 2002-10-15 Augustine Medical, Inc. Covering
US5549908A (en) * 1993-05-20 1996-08-27 The University Of Akron Hydrolytically labile microspheres of polysaccharide crosslinked with cyanogen halide and their application in wound dressings
US5901848A (en) * 1993-05-20 1999-05-11 Worlds Class Packaging Systems, Inc. Plural atmosphere package
US5466465A (en) * 1993-12-30 1995-11-14 Harrogate Holdings, Limited Transdermal drug delivery system
US5605664A (en) * 1994-07-13 1997-02-25 I-Stat Corporation Methods and apparatus for rapid equilibration of dissolved gas composition
US5964721A (en) * 1995-02-21 1999-10-12 Augustine Medical, Inc. Wound covering
US5855570A (en) * 1995-04-12 1999-01-05 Scherson; Daniel A. Oxygen producing bandage
US5578022A (en) * 1995-04-12 1996-11-26 Scherson; Daniel A. Oxygen producing bandage and method
US5788682A (en) * 1995-04-28 1998-08-04 Maget; Henri J.R. Apparatus and method for controlling oxygen concentration in the vicinity of a wound
US6248380B1 (en) * 1995-06-06 2001-06-19 Cryovac, Inc. Package having a dual-film lid comprising a gas-impermeable film and a delaminatable, gas-permeable film
US5792090A (en) * 1995-06-15 1998-08-11 Ladin; Daniel Oxygen generating wound dressing
US5707499A (en) * 1995-10-06 1998-01-13 Ceramatec, Inc. Storage-stable, fluid dispensing device using a hydrogen gas generator
US5827530A (en) * 1996-02-05 1998-10-27 Reed, Jr.; Fred Dewitt Fillable patch for dermal or transdermal delivery
US5948457A (en) * 1996-04-03 1999-09-07 Tenneco Packaging Inc. Modified atmosphere package
US5662625A (en) * 1996-05-06 1997-09-02 Gwr Medical, L.L.P. Pressure controllable hyperbaric device
US5762678A (en) * 1996-08-05 1998-06-09 Hiles; Maurice Conversion of cellulosic waste to a soil improvement complex
US5780048A (en) * 1997-03-20 1998-07-14 Lee; Chung Chih First aid bandage dressing system and method of application thereof
US5865722A (en) * 1997-04-04 1999-02-02 Numotech, Incorporated Shape-adaptable topical hyperbaric oxygen chamber
US6073759A (en) * 1997-04-10 2000-06-13 Johns Hopkins University Pre-filled package containing unit dose of medical gas and method of making same
US5916615A (en) * 1997-06-18 1999-06-29 W. R. Grace & Co.-Conn. Case-ready packages having smooth, gas-permeable substrates on the bottoms thereof to reduce or prevent discoloration when placed in a stack
US6251344B1 (en) * 1997-06-27 2001-06-26 Quantum Group, Inc. Air quality chamber: relative humidity and contamination controlled systems
US6210725B1 (en) * 1998-05-08 2001-04-03 Tres Fresh, Llc Method for creating modified atmosphere packaging
US6548132B1 (en) * 1998-07-23 2003-04-15 Landec Corporation Packaging biological materials
US6458109B1 (en) * 1998-08-07 2002-10-01 Hill-Rom Services, Inc. Wound treatment apparatus
US6238677B1 (en) * 1998-08-18 2001-05-29 The United States Of America As Represented By The Secretary Of Agriculture Starch microcapsules for delivery of active agents
US6877601B1 (en) * 1998-10-29 2005-04-12 Tres Fresh L.L.C. Packaging system for extending the shelf life of moisture-containing foods
US6565936B1 (en) * 1998-11-03 2003-05-20 Mitsubishi Polyester Film Gmbh Film laminate comprising a biaxially oriented polyester film with high oxygen barrier, its use and a process for its production
US6113922A (en) * 1998-11-13 2000-09-05 Swenson; Russell H. Compositions expressing a pressure of carbon dioxide for improved healing of wounds
US6256905B1 (en) * 1999-02-12 2001-07-10 Galen White Controlled atmosphere shipping/storage system and method
US6284941B1 (en) * 1999-03-09 2001-09-04 Craig M. Cox Bandage having a scar treatment pad for scar management and scar repair
US6465709B1 (en) * 1999-07-08 2002-10-15 Johnson & Johnson Consumer Companies, Inc. Exothermic bandage
US6572594B2 (en) * 1999-08-18 2003-06-03 R.S. Medical Equipment Llc Skin treatment using neuromuscular stimulation and a treatment gas containing medicine
US20010020146A1 (en) * 1999-08-18 2001-09-06 Satterfield Elaine T. Skin treatment apparatus and method
US6471685B1 (en) * 2000-05-18 2002-10-29 David James Johnson Medical dressing assembly and associated method of using the same
US20040116770A1 (en) * 2000-10-17 2004-06-17 O'connor Michael Controlled environment device
US6432077B1 (en) * 2000-12-26 2002-08-13 Sensormedics Corporation Device and method for treatment of surface infections with nitric oxide
US6451590B1 (en) * 2001-02-01 2002-09-17 Clemson University Apparatus and method for propagating plants
US6767342B1 (en) * 2001-04-23 2004-07-27 Evelyna D. Cantwell Oxygen bandage system
US20050112245A1 (en) * 2001-07-25 2005-05-26 Delduca Gary R. Modified atmospheric package
US6683747B2 (en) * 2001-11-02 2004-01-27 Seagate Technology Llc Internal disc drive gas reservoir
US7033823B2 (en) * 2002-01-31 2006-04-25 Cesco Bioengineering, Inc. Cell-cultivating device
US20030167556A1 (en) * 2002-03-05 2003-09-11 Consumers Choice Systems, Inc. Methods and devices for transdermal delivery of anti-aging compounds for treatment and prevention of facial or neck skin aging
US20030190367A1 (en) * 2002-04-05 2003-10-09 David Balding Oxygen enriched implant for orthopedic wounds and method of packaging and use
US20040054338A1 (en) * 2002-09-13 2004-03-18 Farhad Bybordi Closed wound drainage system
US20040057906A1 (en) * 2002-09-24 2004-03-25 Li-Chien Hsu Perfluorocarbon emulsions with non-fluorinated surfactants
US20060111657A1 (en) * 2002-09-27 2006-05-25 Deborah Addison Wound treatment device
US20060142684A1 (en) * 2003-04-11 2006-06-29 Shanbrom Technologies, Llc Oxygen releasing material
US7964766B2 (en) * 2003-10-28 2011-06-21 Smith & Nephew Plc Wound cleansing apparatus in-situ

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010027632A2 (en) * 2008-08-15 2010-03-11 Oxyband Technologies, Inc. Multiple cell therapeutic diffusion device
WO2010027632A3 (en) * 2008-08-15 2010-06-17 Oxyband Technologies, Inc. Hermetically sealed package for a therapeutic diffusion device
CN102215899A (en) * 2008-08-15 2011-10-12 奥西班德科技公司 Multiple cell therapeutic diffusion device
US20100038280A1 (en) * 2008-08-15 2010-02-18 Franklin Amie B Hermetically Sealed Package for A Therapeutic Diffusion Device
EP2519297A2 (en) * 2009-12-31 2012-11-07 Ohio University Systems and methods for promoting wound healing
EP2519297A4 (en) * 2009-12-31 2013-08-21 Univ Ohio Systems and methods for promoting wound healing
US9511196B2 (en) 2009-12-31 2016-12-06 Ohio University Systems and methods for promoting wound healing
US11090409B2 (en) * 2010-04-09 2021-08-17 Kci Licensing, Inc. Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds
US11896733B2 (en) 2010-04-09 2024-02-13 3M Innovative Properties Company Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds
US20150128949A1 (en) * 2011-02-11 2015-05-14 Koninklijke Philips Patient interface device having headgear providing integrated gas flow and delivery
USD746478S1 (en) * 2013-07-05 2015-12-29 Mölnlycke Health Care Ab Wound filler
USD783843S1 (en) 2013-07-05 2017-04-11 Mölnlycke Health Care Ab Wound filler
US10272175B2 (en) 2013-11-26 2019-04-30 Avent, Inc. Foams for oxygen delivery to wounds
US10568771B2 (en) 2014-01-24 2020-02-25 Avent, Inc. Traumatic wound dressing system with conformal cover
US10327956B2 (en) 2014-01-24 2019-06-25 Avent, Inc. Traumatic wound dressing system with wrap
US10293073B2 (en) 2014-08-29 2019-05-21 Avent, Inc. Moisture management for wound care
US10775645B2 (en) * 2016-04-14 2020-09-15 Johnson & Johnson Vision Care, Inc. Methods and apparatus to enhance oxygen concentrations for advanced ophthalmic devices
US20180203253A1 (en) * 2016-04-14 2018-07-19 Johnson & Johnson Vision Care, Inc. Methods and apparatus to enhance oxygen concentrations for ophthalmic devices
US20180203254A1 (en) * 2016-04-14 2018-07-19 Johnson & Johnson Vision Care, Inc. Methods and apparatus to enhance oxygen concentrations for advanced ophthalmic devices
US11547611B2 (en) 2017-09-22 2023-01-10 Kci Licensing, Inc. Wound dressings and systems with high-flow therapeutic gas sources for topical wound therapy and related methods
US11141523B2 (en) 2017-10-26 2021-10-12 Kci Licensing, Inc. Wound dressings and systems for effluent management of topical wound therapy and related methods
WO2019139829A1 (en) * 2018-01-10 2019-07-18 Kci Licensing, Inc. Negative pressure wound therapy dressings with local oxygen generation for topical wound therapy and related methods
US11576818B2 (en) 2018-01-10 2023-02-14 Kci Licensing, Inc. Negative pressure wound therapy dressings with local oxygen generation for topical wound therapy and related methods
EP4146323A1 (en) * 2020-05-04 2023-03-15 Fisher & Paykel Healthcare Limited Wound edge diffuser

Also Published As

Publication number Publication date
US20130112077A1 (en) 2013-05-09
US8166731B2 (en) 2012-05-01
US8900209B2 (en) 2014-12-02
US20060248859A1 (en) 2006-11-09

Similar Documents

Publication Publication Date Title
US8166731B2 (en) Method and apparatus for supplying gas to an area
AU2006214192B2 (en) Method and apparatus for supplying gas to an area
US11497652B2 (en) Auto-replenishing, wound-dressing apparatus and method
US7263814B2 (en) Method and apparatus for supplying gas to an area
JP5172940B2 (en) Topical skin delivery device for nitric oxide delivery
AU2004249259B2 (en) Method and apparatus for supplying gas to an area
US5672167A (en) Controlled release osmotic pump
US7762045B2 (en) Method and apparatus for supplying gas to an area
US20110257610A1 (en) Therapeutic Diffusion Wound Dressing and Filling Method
WO2006066125A3 (en) Device and method for the vacuum infusion of a porous medical implant
US20140328816A1 (en) Packaged probiotic composition and uses thereof
WO2011119760A2 (en) Therapeutic diffusion wound dressing and filling method

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- AFTER EXAMINER'S ANSWER OR BOARD OF APPEALS DECISION